<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">91729</article-id><article-id pub-id-type="doi">10.7554/eLife.91729</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.91729.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Single-cell ‘omic profiles of human aortic endothelial cells in vitro and human atherosclerotic lesions ex vivo reveal heterogeneity of endothelial subtype and response to activating perturbations</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-319702"><name><surname>Adelus</surname><given-names>Maria L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9676-9214</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-321834"><name><surname>Ding</surname><given-names>Jiacheng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-321835"><name><surname>Tran</surname><given-names>Binh T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-321836"><name><surname>Conklin</surname><given-names>Austin C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-321837"><name><surname>Golebiewski</surname><given-names>Anna K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-330815"><name><surname>Stolze</surname><given-names>Lindsey K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-321838"><name><surname>Whalen</surname><given-names>Michael B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-321839"><name><surname>Cusanovich</surname><given-names>Darren A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6889-0095</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-242798"><name><surname>Romanoski</surname><given-names>Casey E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0149-225X</contrib-id><email>cromanoski@arizona.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03m2x1q45</institution-id><institution>The Department of Cellular and Molecular Medicine, The University of Arizona</institution></institution-wrap><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03m2x1q45</institution-id><institution>The Clinical Translational Sciences Graduate Program, The University of Arizona</institution></institution-wrap><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03m2x1q45</institution-id><institution>Asthma and Airway Disease Research Center, The University of Arizona</institution></institution-wrap><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Seldin</surname><given-names>Marcus M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gyf1771</institution-id><institution>University of California, Irvine</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Ajijola</surname><given-names>Olujimi A</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>05</day><month>04</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP91729</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-08-22"><day>22</day><month>08</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-08-10"><day>10</day><month>08</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.04.03.535495"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-12-04"><day>04</day><month>12</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.91729.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-03-04"><day>04</day><month>03</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.91729.2"/></event></pub-history><permissions><copyright-statement>© 2023, Adelus et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Adelus et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-91729-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-91729-figures-v1.pdf"/><related-article related-article-type="commentary" ext-link-type="doi" xlink:href="10.7554/elife.97247" id="ra1"/><abstract><p>Heterogeneity in endothelial cell (EC) sub-phenotypes is becoming increasingly appreciated in atherosclerosis progression. Still, studies quantifying EC heterogeneity across whole transcriptomes and epigenomes in both in vitro and in vivo models are lacking. Multiomic profiling concurrently measuring transcriptomes and accessible chromatin in the same single cells was performed on six distinct primary cultures of human aortic ECs (HAECs) exposed to activating environments characteristic of the atherosclerotic microenvironment in vitro. Meta-analysis of single-cell transcriptomes across 17 human ex vivo arterial specimens was performed and two computational approaches quantitatively evaluated the similarity in molecular profiles between heterogeneous in vitro and ex vivo cell profiles. HAEC cultures were reproducibly populated by four major clusters with distinct pathway enrichment profiles and modest heterogeneous responses: EC1-angiogenic, EC2-proliferative, EC3-activated/mesenchymal-like, and EC4-mesenchymal. Quantitative comparisons between in vitro and ex vivo transcriptomes confirmed EC1 and EC2 as most canonically EC-like, and EC4 as most mesenchymal with minimal effects elicited by siERG and IL1B. Lastly, accessible chromatin regions unique to EC2 and EC4 were most enriched for coronary artery disease (CAD)-associated single-nucleotide polymorphisms from Genome Wide Association Studies (GWAS), suggesting that these cell phenotypes harbor CAD-modulating mechanisms. Primary EC cultures contain markedly heterogeneous cell subtypes defined by their molecular profiles. Surprisingly, the perturbations used here only modestly shifted cells between subpopulations, suggesting relatively stable molecular phenotypes in culture. Identifying consistently heterogeneous EC subpopulations between in vitro and ex vivo models should pave the way for improving in vitro systems while enabling the mechanisms governing heterogeneous cell state decisions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>endothelial cells</kwd><kwd>ERG</kwd><kwd>inflammation</kwd><kwd>atherosclerosis</kwd><kwd>vascular biology</kwd><kwd>epigenetics</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01HL147187</award-id><principal-award-recipient><name><surname>Romanoski</surname><given-names>Casey E</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35GM137896</award-id><principal-award-recipient><name><surname>Cusanovich</surname><given-names>Darren A</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F30HL162469</award-id><principal-award-recipient><name><surname>Adelus</surname><given-names>Maria L</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32HL7249-45</award-id><principal-award-recipient><name><surname>Adelus</surname><given-names>Maria L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Primary endothelial cell cultures contain markedly heterogeneous cell subtypes that exhibit distinct molecular responses to disease-relevant exposures.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Endothelial cells (ECs) in the vascular endothelium maintain hemostasis, mediate vasodilation, and regulate the migration of leukocytes into tissues during inflammation. Dysfunctions of the endothelium are a hallmark of the aging process and are also an important feature of diseases, including atherosclerosis. Atherosclerosis is an inflammatory process fueled by cholesterol and leukocyte accumulation in the sub-endothelial layer of arteries. It is the underlying pathobiology of ischemic heart disease and the leading cause of morbidity and mortality worldwide due to heart attack and stroke (<xref ref-type="bibr" rid="bib8">Brown et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Hajra et al., 2000</xref>; <xref ref-type="bibr" rid="bib6">Birdsey et al., 2015</xref>). Atherosclerosis of the coronary arteries is estimated to be about 50% genetic, with hundreds of genomic loci contributing to genetic risk (<xref ref-type="bibr" rid="bib53">Marenberg et al., 1994</xref>; <xref ref-type="bibr" rid="bib4">Aragam et al., 2022</xref>; <xref ref-type="bibr" rid="bib79">Tcheandjieu et al., 2022</xref>). A major opportunity for better understanding the molecular basis for how disease progresses lies in identifying the genomic and downstream functions impaired by risk variants in disease-relevant cell types. Genetic studies are increasingly suggesting that a significant proportion of genetic risk for atherosclerosis is encoded in perturbed functions of vascular ECs (<xref ref-type="bibr" rid="bib4">Aragam et al., 2022</xref>; <xref ref-type="bibr" rid="bib79">Tcheandjieu et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">Kessler and Schunkert, 2021</xref>).</p><p>Single-cell sequencing technologies have begun to characterize the extent of EC molecular diversity in vitro and in vivo (<xref ref-type="bibr" rid="bib94">Zhao et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Li et al., 2019</xref>; <xref ref-type="bibr" rid="bib36">Kalluri et al., 2019</xref>; <xref ref-type="bibr" rid="bib49">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib37">Kalucka et al., 2020</xref>; <xref ref-type="bibr" rid="bib69">Rohlenova et al., 2020</xref>; <xref ref-type="bibr" rid="bib95">Zhao et al., 2021a</xref>; <xref ref-type="bibr" rid="bib89">Xu et al., 2020</xref>; <xref ref-type="bibr" rid="bib16">Cheng et al., 2021</xref>; <xref ref-type="bibr" rid="bib40">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib3">Andueza et al., 2020</xref>; <xref ref-type="bibr" rid="bib80">Tombor et al., 2020</xref>). Genetically engineered, lineage-traced mouse models have also been instrumental for identifying which cells in atherosclerotic plaques arose from EC origin. These studies have demonstrated that many cells of EC origin in plaques lack canonical EC marker genes and luminal location (<xref ref-type="bibr" rid="bib25">Evrard et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2012</xref>). As many as one-third of mesenchymal-like cells in plaques have been reported to be of endothelial origin (<xref ref-type="bibr" rid="bib25">Evrard et al., 2016</xref>), suggesting that phenotypic transition from endothelial to mesenchymal (EndMT) is a feature of atherosclerosis; however, whether EndMT is a cause or bystander of atherogenesis or plaque rupture is not fully understood. Although lineage tracing is not possible in humans, immunocytochemical techniques suggest that EC heterogeneity is prevalent in atherosclerotic vessels. These studies have described an unexpectedly large number of cells co-expressing pairs of endothelial and mesenchymal proteins, including fibroblast-activating protein/von Willebrand factor (FAP/VWF), fibroblast-specific protein-1/VWF (FSP-1/VWF), FAP/platelet-endothelial cell adhesion molecule-1 (CD31 or PECAM-1), FSP-1/CD31 (<xref ref-type="bibr" rid="bib25">Evrard et al., 2016</xref>), phosphorylation of TGFB signaling intermediary SMAD2/FGF receptor 1 (p-SMAD2/FGFR1) (<xref ref-type="bibr" rid="bib14">Chen et al., 2015</xref>), and α-smooth muscle actin (αSMA)/PECAM-1 (<xref ref-type="bibr" rid="bib57">Moonen et al., 2015</xref>). An important implication of this result is that the use of canonical EC markers to isolate or identify ECs will likely omit certain EC populations. The extent of EC molecular and functional heterogeneity within a tissue during homeostasis and during disease is not well understood. One notable study exemplifying EC heterogeneity demonstrated that the EC-marker gene von Willebrand Factor (<italic>VWF</italic>) was expressed only in a subset of ECs from the same murine vessel, and the penetrance of <italic>VWF</italic> expression across ECs was tissue-specific (<xref ref-type="bibr" rid="bib92">Yuan et al., 2016</xref>). In a related study, expression of the leukocyte adhesion molecule <italic>VCAM-1</italic> was found to be upregulated by the pro-inflammatory cytokine tumor necrosis factor α only in some of the ECs of a monolayer (<xref ref-type="bibr" rid="bib82">Turgeon et al., 2020</xref>). In both studies, variability in DNA methylation on CpG dinucleotides at the gene promoters negatively correlated with <italic>VWF</italic> and <italic>VCAM-1</italic> expression. These findings raise the question as to how many molecular programs exist within ECs of a same tissue or culture, how this heterogeneity influences response to cellular perturbations, and what factors regulate these cellular states.</p><p>There are notable benefits and limitations for studying heterogeneity using in vitro and in vivo approaches in atherosclerosis research. In vitro approaches provide unique opportunities for interrogating consequences of genetic and chemical perturbations in highly controlled environments and are adept at identifying mechanistic relationships on accelerated timelines. In vivo approaches benefit from the complexity of the crosstalk among all cell types and tissues of the organism and are adept for identifying how perturbations manifest in living systems. It reasons that the integration of results from both approaches will best accelerate discovery. However, comprehensive analysis comparing heterogeneity of vascular ECs observed in vivo and in vitro remains unexplored. In the current study, we performed meta-analysis on four human in/ex vivo single-cell transcriptomic datasets (<xref ref-type="bibr" rid="bib63">Pan et al., 2020</xref>; <xref ref-type="bibr" rid="bib2">Alsaigh et al., 2022</xref>; <xref ref-type="bibr" rid="bib17">Chowdhury et al., 2022</xref>; <xref ref-type="bibr" rid="bib87">Wirka et al., 2019</xref>), containing 17 arterial samples, from mild-to-moderate calcified atherosclerotic plaques to evaluate the ability of the in vitro EC models to recapitulate molecular signatures observed in human atherosclerosis.</p><p>Human aortic endothelial cells (HAECs) are among the most appropriate cell type for in vitro modeling of the arterial endothelium in atherosclerosis research insofar as they are human cells, they are more readily available than coronary artery ECs, they are not of venous origin like human umbilical vein ECs, and they can be isolated from explants of healthy donor hearts during transplantation. We set forth in the current study to quantify heterogeneity among HAECs using multimodal sequencing that simultaneously measures transcripts using RNA-seq and accessible chromatin using ATAC-seq from the same barcoded nuclei. To provide estimates for heterogeneity due to genetic background, we molecularly phenotyped HAECs from six genetically distinct human donors. We also quantified single-cell responses to three perturbations known to be important in EC biology and atherosclerosis. The first was activation of transforming growth factor beta (TGFB) signaling, which is a hallmark of phenotypic transition and a regulator of EC heterogeneity (<xref ref-type="bibr" rid="bib25">Evrard et al., 2016</xref>; <xref ref-type="bibr" rid="bib83">van Meeteren and ten Dijke, 2012</xref>). The second was stimulation with the pro-inflammatory cytokine interleukin-1 beta (IL1B), which has been shown to model inflammation and EndMT in vitro (<xref ref-type="bibr" rid="bib9">Bujak et al., 2008</xref>; <xref ref-type="bibr" rid="bib10">Bujak and Frangogiannis, 2009</xref>; <xref ref-type="bibr" rid="bib52">Maleszewska et al., 2013</xref>; <xref ref-type="bibr" rid="bib12">Chaudhuri et al., 2007</xref>; <xref ref-type="bibr" rid="bib71">Sánchez-Duffhues et al., 2019</xref>), and whose inhibition reduced adverse cardiovascular events in a large clinical trial (<xref ref-type="bibr" rid="bib67">Ridker et al., 2017</xref>). The third perturbation utilized in our study was knockdown of the ETS-related gene (<italic>ERG</italic>), which encodes a transcription factor of critical importance for EC fate specification and homeostasis (<xref ref-type="bibr" rid="bib74">Sperone et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Fish et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Lathen et al., 2014</xref>; <xref ref-type="bibr" rid="bib84">Vijayaraj et al., 2012</xref>; <xref ref-type="bibr" rid="bib34">Hogan et al., 2017</xref>).</p><p>Lastly, we examine whether epigenetic landscapes among heterogeneous EC subtypes observed in this study were differentially enriched for coronary artery disease (CAD) genetic risk variants. Taken together, this study provides evidence that EC heterogeneity is prevalent in vivo and in vitro and that not all ECs respond similarly to activating perturbations.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>EC single-cell transcriptomic profiles reveal a heterogeneous population</title><p>To systematically uncover the heterogeneity of molecular landscapes in ECs at single-cell resolution, we cultured primary HAECs isolated from luminal digests of ascending aortas from six de-identified heart transplant donors at low passage (passages 3–6) (<xref ref-type="bibr" rid="bib60">Navab et al., 1988</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). Using the 10X Genomics multiome kit (<xref ref-type="bibr" rid="bib28">Genomics x, 2022a</xref>), single-nucleus mRNA expression (snRNA-seq) and chromatin accessibility (snATAC-seq) data were collected simultaneously for a total of 15,220 nuclei after stringent quality control (‘Materials and methods’). RNA and ATAC data were integrated separately by treatment condition and then with each other as reported previously (‘Materials and methods’; <xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Human aortic endothelial cell (HAEC) transcriptomic profiling discover a heterogeneous cell population.</title><p>(<bold>A</bold>) Schematic diagram of the experimental design. Endothelial cells (ECs) were isolated from six human heart transplant donor’s ascending aortic trimmings and treated with IL1B, TGFB2, or siERG (ERG siRNA) for 7 d. (<bold>B</bold>) Weighted nearest-neighbor UMAP (<sub>WNN</sub>UMAP) of aggregate cells from all perturbations and donors is shown. Each dot represents a cell, and the proximity between each cell approximates their similarity of both transcriptional and epigenetic profiles. Colors denote cluster membership. (<bold>C</bold>) The proportion of cells from each donor for each EC subtype. (<bold>D</bold>) Gene expression across top markers for each cluster including pan EC (<italic>ERG</italic>), EC1 (<italic>KDR</italic>), EC2 (<italic>TOP2A</italic>), and EC4 (<italic>COL1A1</italic>). (<bold>E</bold>) Top markers for pan EC (<italic>PECAM1</italic>, <italic>CDH5</italic>, <italic>ERG</italic>), EC1 (<italic>KDR</italic>, <italic>PGF</italic>), EC2 (<italic>CENPE</italic>, <italic>TOP2A</italic>), EC3 (<italic>SEMA3C</italic>, <italic>ACKR3</italic>), EC4 (<italic>COL1A1</italic>, <italic>COL6A1</italic>), and EC5 (<italic>LRRC17</italic>, <italic>LAMA2</italic>). The size of the dot represents the percentage of cells within each EC subtype that express the given gene, while the shade of the dot represents the level of average expression (‘Avg. Expn.’ in the legend). (<bold>F</bold>) Heatmap of pathway enrichment analysis (PEA) results from submitting top 200 differentially expressed genes (DEGs; by ascending p-value) between EC subtypes. Rows (pathways) and columns (EC subtypes) are clustered based on -Log<sub>10</sub>(P). (<bold>G</bold>) Violin plots of top Metascape pathway module scores across EC subtypes. Module scores are generated for each cell barcode with the Seurat function AddModuleScore().</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Marker genes and pathways for endothelial clusters.</title><p>(<bold>A</bold>) Violin plots of representative marker genes for angiogenic EC1 (<italic>KDR</italic>, <italic>GAB1</italic>, <italic>PGF</italic>, <italic>NRP1</italic>), proliferative EC2 (<italic>CENPE</italic>, <italic>CENPF</italic>, <italic>KIF11</italic>, <italic>KIF4A</italic>), and mesenchymal EC4 (<italic>COL1A1</italic>, <italic>COL1A2</italic>, <italic>COL3A1</italic>, <italic>COL5A1</italic>) sub-phenotypes. (<bold>B</bold>) Top 20 pathway enrichment analysis (PEA) results from submitting top 200 differentially expressed genes (DEGs; by ascending p-value) regulated in EC3 versus EC1-2 and EC4-5. (<bold>C</bold>) Top 20 Gene Ontology (GO) PEA results from submitting top 200 DEGs (by ascending p-value) regulated in EC3 versus EC1-2 and EC4-5.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Violin plot of <italic>XIST</italic> showing expected expression in female in vitro donor cells (1 and 3) and lack of expression in male in vitro donor cells (2, 4, 5, and 6).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig1-figsupp2-v1.tif"/></fig></fig-group><p>snRNA-seq libraries were sequenced to a median depth of 29,732–84,476 reads and 2481–3938 transcripts per nucleus (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a and b</xref>). Five distinct EC subtypes (EC1, EC2, EC3, EC4, and EC5) were detected from the fully integrated dataset, which included all donors, treatments, and data types (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Subtypes EC1 and EC3 comprised cells from all donors, whereas EC2 and EC4 contained cells from most donors, and EC5 was nearly exclusively populated by cells from a single donor (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>). Because we do not observe EC5 across multiple individuals, we chose not to focus additional analysis on this subtype. Pathway enrichment of marker genes revealed EC1 to exhibit an angiogenic phenotype (WP4331, p-value 4.0 × 10<sup>–9</sup>; GO:0038084, p-value 1.5 × 10<sup>–9</sup>) with enriched transcripts including <italic>KDR</italic>, <italic>GAB1</italic>, <italic>PGF</italic>, and <italic>NRP2</italic> (<xref ref-type="fig" rid="fig1">Figure 1D–G</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). EC2 was enriched in proliferation (GO:1903047, p-value 7.4 × 10<sup>–35</sup>) with characteristic markers <italic>CENPE</italic>, <italic>CENPF</italic>, <italic>KIF11</italic>, <italic>KIF4A,</italic> and <italic>TOP2A</italic> (<xref ref-type="fig" rid="fig1">Figure 1D–G</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). EC3 displayed enrichment in the ‘regulation of smooth muscle cell proliferation’ (GO:0048660; p-value 1.1 × 10<sup>–10</sup>) (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). From the top 200 differentially expressed genes (DEGs) for EC3, we observed additional pathways enriched, including NABA CORE MATRISOME (M5884; p-value 1 × 10<sup>–34</sup>) and locomotion (GO:0040011; p-value 1.2 × 10<sup>–15</sup>), suggesting an activated mesenchymal-like phenotype (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B and C</xref>). A fourth subset, EC4, demonstrates enrichment in ECM organization (GO:0097435; p-value 3.2 × 10<sup>–19</sup>), a process characteristic of mesenchymal cells, with distinctive expression of collagen genes, including <italic>COL1A1</italic>, <italic>COL1A2</italic>, <italic>COL3A1</italic>, and <italic>COL5A1</italic> (<xref ref-type="fig" rid="fig1">Figure 1D–G</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib19">Dahal et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Kovacic et al., 2019</xref>). Top marker genes and pathways for each EC subtype are in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d and e</xref>. These observations are in line with previous reports of angiogenic, proliferative, mesenchymal, and pro-coagulatory EC subtypes within ex vivo models (<xref ref-type="bibr" rid="bib47">Li et al., 2019</xref>; <xref ref-type="bibr" rid="bib36">Kalluri et al., 2019</xref>; <xref ref-type="bibr" rid="bib95">Zhao et al., 2021a</xref>; <xref ref-type="bibr" rid="bib80">Tombor et al., 2020</xref>; <xref ref-type="bibr" rid="bib7">Bondareva et al., 2022</xref>) and underscore the heterogeneity of transcriptomic profiles in cultured HAECs.</p></sec><sec id="s2-2"><title>EC subtypes exhibit distinct open chromatin profiles and enriched motifs</title><p>To investigate how different transcriptional signatures across ECs correspond to distinct chromatin states, we utilized the snATAC-seq portion of the multiome dataset. The snATAC-seq data were sequenced to a median depth of 22,939–126,122 reads with 3480–19,259 peaks called per nucleus (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b and f</xref>). Of the 204,904 total identified peaks, 13,731 were differential across subtypes, with 79–8091 peaks uniquely accessible per EC subtype (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>). Over 80% of total peaks were intergenic or intronic (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>) and most unique peaks were from EC2 and EC4.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Endothelial cells (ECs) have epigenetically distinct cell states.</title><p>(<bold>A</bold>) Upset plot of differential peaks across EC subtypes. Intersection size represents the number of genes at each intersection, while set size represents the number of genes for each EC subtype. (<bold>B</bold>) Genomic annotation for the complete peak set. (<bold>C</bold>) Heatmap of top transcription factors (TFs) from motif enrichment analysis for marker peaks in each EC subtype. Top TFs for each EC subtype are selected based on ascending p-value. Rows (TFs) and columns (EC subtype) are clustered based on enrichment score (ES). (<bold>D</bold>) Feature plots and position weight matrices (PWMs) for top TF binding motifs for EC1 (TCF12), EC2 (ETV1), EC3 (GATA5), and EC4 (TEAD3). Per-cell motif activity scores are computed with chromVAR, and motif activities per cell are visualized using the Signac function FeaturePlot. (<bold>E</bold>), PWMs comparing Jaspar 2020 ETV1 motif to ERG motif reported in Hogan et al.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig2-v1.tif"/></fig><p>Transcription factor (TF) motif enrichment analysis using Signac (<xref ref-type="bibr" rid="bib77">Stuart et al., 2021</xref>) was performed on differentially accessible regions (DARs) per EC subtype (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). It is important to note that TFs within a TF family may share DNA-binding motifs and may not be distinguished by motifs alone. As a result, TF names from the Jaspar database (<xref ref-type="bibr" rid="bib27">Fornes et al., 2020</xref>) indicate the TF family. We find the basic helix-loop-helix (<italic>bHLH</italic>) motif defined by the core sequence CANNTG enriched in EC1 peaks, including enrichments for ASCL2 (adjusted p-value 3.9 × 10<sup>–50</sup>), TCF12 (adjusted p-value 1.7 × 10<sup>–21</sup>), and BHLHE22(var.2) (adjusted p-value 5.7 × 10<sup>–48</sup>) (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>). ETS motifs, including ETV1 (adjusted p-value 3.2 × 10<sup>–42</sup> and 5.3 × 10<sup>–249</sup>, for EC1-2, respectively), SPIB (adjusted p-value 7.9 × 10<sup>–22</sup> and 2.5 × 10<sup>–236</sup>, respectively), and GABPA (adjusted p-value 2.7 × 10<sup>–41</sup> and 4.3 × 10<sup>–244</sup>, respectively), were also enriched in EC1 as well as in EC2 peaks. These data are consistent with known roles for ETS TFs, including ERG and FLI1, in governing angiogenic and homeostatic endothelial phenotypes (<xref ref-type="bibr" rid="bib59">Nagai et al., 2018</xref>). Given that <italic>ERG</italic> expression (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) correlated with incidence of the ETS motif in open chromatin (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) across the nuclei, ERG is likely driving the EC1-2 sub-phenotypes. The near-exact match in motifs between the ETV1 motif position weight matrix in Jaspar and the de novo enriched motif from ERG ChIP-seq in human aortic ECs (<xref ref-type="bibr" rid="bib34">Hogan et al., 2017</xref>) further supports this conclusion (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). In addition to ETS motifs, EC2 was enriched in ZFX (adjusted p-value 4.2 × 10<sup>–86</sup>) and ZNF148 (adjusted p-value 1.1 × 10<sup>–126</sup>), which are C2H2 zinc finger motifs. C2H2 zinc finger motifs, as well as KLF4 (adjusted p-value 5.4 × 10<sup>–32</sup> and 8.4 × 10<sup>–135</sup>, for EC1-2, respectively), also show enrichment in EC1 and EC2. EC3 peaks are enriched for GATA motifs including GATA4 (adjusted p-value 3.1 × 10<sup>–8</sup>), GATA5 (adjusted p-value 8 × 10<sup>–11</sup>), GATA1::TAL1 (adjusted p-value 1.8 × 10<sup>–6</sup>), and bHLH motif BHLHE22(var.2) (adjusted p-value 0.01). EC4 open regions were uniquely enriched for TEA domain (TEAD) factors comprised of motifs named TEAD2 (adjusted p-value 1.2 × 10<sup>–238</sup>), TEAD3 (adjusted p-value 2.1 × 10<sup>–306</sup>), and TEAD4 (adjusted p-value 6.9 × 10<sup>–252</sup>) (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>). Notably, TEAD factors have been found as enriched in vascular smooth muscle cells (VSMCs) (<xref ref-type="bibr" rid="bib87">Wirka et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Örd et al., 2021</xref>), which is consistent with EC4 having the most mesenchymal phenotype of our EC subtypes.</p><p>Taken together, these data demonstrate that EC1 and EC2 are the subtypes most canonically like ‘healthy’ or angiogenic ECs insofar as they exhibit ETS motif enrichments. Additionally, we conclude that EC4 is the most mesenchymal EC insofar as it exhibits TEAD factor enrichments.</p></sec><sec id="s2-3"><title>EC-activating perturbations modestly shift cells into the EC3 subtype</title><p>Embedded in the dataset of this study were three experimental conditions known to promote EndMT along with their respective controls. Each experimental condition was administered to between three and five genetically distinct HAEC cultures. The conditions included 7-day exposure to IL1B (10 ng/ml), 7-day exposure to TGFB2 (10 ng/ml), and 7-day siRNA-mediated knockdown of ERG (siERG). The control for IL1B and TGFB2 treatments was 7-day growth in matched media lacking cytokine and the control for the siERG condition was transfection with scrambled RNA.</p><p>The UMAP presented in <xref ref-type="fig" rid="fig1">Figure 1</xref> includes all the nuclei profiled across donors and conditions. We hypothesized that EC4, the most mesenchymal cluster, would be enriched for cells exposed to IL1B, TGFB2, and/or siERG relative to the controls thereby consistent with the hypothesis that the EC4 subtype were a consequence of EndMT. Detailed in <xref ref-type="fig" rid="fig3">Figure 3A and B</xref> are the relative proportions of cells from each experimental condition and donor by cluster. Contrary to our hypothesis, the EC4 cluster was not enriched for cells that were treated with cytokine or siERG relative to the controls; in fact, there is a nonstatistically significant trend for decreased numbers of EC4 cells from these conditions relative to controls insofar as all the donors with cells in EC4 show diminished proportions upon perturbation (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The one cluster exhibiting increased proportions of cells upon perturbations was EC3, with three of four EC IL1B-exposed donors having increased proportions in EC3 (p=0.08 by two-sided paired <italic>t</italic>-test; <xref ref-type="fig" rid="fig3">Figure 3A</xref>), four of five TGFB2-exposed donors having increased proportions (p=0.04 by two-sided paired <italic>t</italic>-test; <xref ref-type="fig" rid="fig3">Figure 3A</xref>), and three of three donors having increased EC3 proportions upon ERG knockdown (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Endothelial cell (EC)-activating perturbations modestly shift cells into the EC3 subtype.</title><p>(<bold>A</bold>) The proportion of cells in 7-day control and 7-day IL1B treatment are shown per human aortic endothelial cell (HAEC) donor and cluster on the top and for 7-day control and 7-day TGFB2 on the bottom. (<bold>B</bold>) The proportion of cells in 7-day siSCR control and 7-day siERG knockdown are shown per HAEC donor and cluster. EC1 was omitted in (<bold>A</bold>) due to lack of cells in both conditions.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Annotated western blots for <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref> where the leftmost six wells are shown from left to right as (1) the protein ladder (labeled in kD), (2) the lipofectamine transfected control, (3) the scrambled siRNA control, (4, 5) two lanes using different siRNAs against the TCF4 gene (not relevant to these studies), and lastly, (6) siRNA against ERG.</title><p>The ERG blot (middle) and the H3 blots (bottom) originated from the same gel and membrane, which was cut at about 30 kD, and each piece was blotted for either anti-ERG antibody or anti-H3 antibody.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-91729-fig3-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Original western blots for ERG, annotated and uncropped.</title><p>Lanes are the same as described in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-91729-fig3-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Original western blots for H3, annotated and uncropped.</title><p>Lanes are the same as described in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-91729-fig3-data3-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title>Original western blots for ERG, unannotated and uncropped.</title><p>Lanes are the same as described in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-91729-fig3-data4-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata5"><label>Figure 3—source data 5.</label><caption><title>Original western blots for H3, unannotated and uncropped.</title><p>Lanes are the same as described in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-91729-fig3-data5-v1.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Principal component analysis using RNA-seq data.</title><p>(<bold>A</bold>) Principal component analysis (PCA) of EC1-4 snRNA-seq samples +/-siERG or control across donor replicates. (<bold>B</bold>) PCA of EC1-4 snRNA-seq samples +/-TGFB2 or control across donor replicates. (<bold>C</bold>) PCA of EC1-4 snRNA-seq samples +/-IL1B or control across donor replicates.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Receptor expression profiles across endothelial clusters.</title><p>(<bold>A</bold>) Feature plots of expression of TGFB pathway receptors: <italic>TGFBR1</italic>, <italic>TGFBR2</italic>, and <italic>ACVRL1</italic>. (<bold>B</bold>) Feature plots of IL1B pathway receptors: <italic>IL1R1</italic>, <italic>IL1R2</italic>, <italic>IL1RL1</italic>, and <italic>IL1RL2</italic>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Validation of ERG knockdown.</title><p>(<bold>A</bold>) qPCR results for ERG knockdown across donors. (<bold>B</bold>) Western blot representing a typical knockdown of siERG with the siRNA pools used in this study. TCF4 samples are irrelevant for the purpose of this study.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig3-figsupp3-v1.tif"/></fig></fig-group><p>In addition to heterogeneity across EC clusters, data in <xref ref-type="fig" rid="fig3">Figure 3</xref> underscores that there is heterogeneity among EC cultures. To quantify this effect, we performed principal component analysis (PCA) to evaluate the overall contributions that donor and experimental conditions have on variance in this dataset. We found that pro-EndMT perturbations elicited greater variance in RNA expression (38–56% of variance) than donor (17%–27% variance) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–C</xref>), supporting that the transcriptional and epigenetic programs elicited by experimental conditions have a greater overall consequence than donor. This finding provides the opportunity to elucidate how different EC clusters respond to pro-EndMT exposures across genetically distinct ECs.</p></sec><sec id="s2-4"><title>Pro-EndMT perturbations in vitro elicit EC subtype-specific transcriptional responses</title><p>We next sought to evaluate the similarities and differences among pro-EndMT perturbations and evaluate the transcriptional response elicited in each EC subtype. Differential gene expression analysis was performed using pseudo-bulked profiles grouped by donor, subcluster, and experimental groupings (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1i</xref>).</p><p>Overall, we found heterogeneity in transcriptional responses across EC subtypes. While EC1 and EC2 transcripts were predominantly perturbed by siERG, the greatest number of transcripts differentially expressed in EC3 were those responsive to IL1B, though siERG and TGFB2 also regulated tens to hundreds of transcripts in EC3. In contrast, transcripts in EC4 were predominantly responsive to TGFB2 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1i</xref>). With respect to EC4, we questioned whether transcripts were predominantly responsive to TGFB2 due to differences in expression of TGFB receptors. While we observed increased TGFBR1 expression in EC4, we observed relatively less expression of TGFBR2 and ACVRL1 in EC4 when compared to EC1, EC2, and EC3 (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). We next questioned whether EC3 transcripts were predominantly responsive to IL1B due to differences in IL1B receptor expression. Notably, we did not observe differences in IL1B receptor expression, suggesting that their transcription is not responsible for divergent EC responses across EC subtypes (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>). Interestingly, we did observe differential expression of IL1RL1 in EC2, which may influence EC2 response to cytokine (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Endothelial cell (EC)-activating perturbations in vitro elicit EC subtype-specific transcriptional responses.</title><p>(<bold>A</bold>) Upset plots of up- and downregulated differentially expressed genes (DEGs) across EC subtypes with siERG (gray), IL1B (pink), and TGFB2 (blue). Upset plots visualize intersections between sets in a matrix, where the columns of the matrix correspond to the sets, and the rows correspond to the intersections. Intersection size represents the number of genes at each intersection. (<bold>B</bold>) Pathway enrichment analysis (PEA) for EC3-4 up- and downregulated DEGs with TGFB2 compared to control media. (<bold>C</bold>) PEA for EC2-4 up- and downregulated DEGs with IL1B compared to control media. (<bold>D</bold>) PEA for EC1-4 up- and downregulated DEGs with siERG compared to siSCR. (<bold>E</bold>) PEA comparing up- and downregulated DEGs that are mutually exclusive and shared between IL1B and siERG in EC3.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Profiles of shared peaks and motif enrichments across endothelial subtypes.</title><p>(<bold>A</bold>) Upset plot of induced peaks for siERG (gray), IL1B (pink), and TGFB2 (blue) across EC1, EC2, EC3, and EC4. Upset plots visualize intersections between sets in a matrix, where the columns of the matrix correspond to the sets, and the rows correspond to the intersections. Intersection size represents the number of genes at each intersection. (<bold>B</bold>) Heatmap of top motifs enriched in IL1B-induced peaks. Top transcription factors (TFs) for each EC subtype are selected based on ascending p-value. Rows (TFs) and columns (EC subtype) are clustered based on enrichment score (ES). (<bold>C</bold>) Heatmap of top motifs enriched in siERG-induced peaks. (<bold>D</bold>), Heatmap of top motifs enriched in TGFB2-induced peaks.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig4-figsupp1-v1.tif"/></fig></fig-group><p>When comparing enriched pathways across perturbations, we observed that over 80% of transcripts differentially expressed by a treatment in EC4 were in response to TGFB2 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1i</xref>). TGFB2-affected transcripts for EC4 were enriched in invadopodia formation (R-HAS-8941237; p-value 2.7 × 10<sup>–7</sup>) and anchoring fibril formation (R-HAS-2214320; p-value 3.6 × 10<sup>–7</sup>) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Notably, TGFB2-affected genes for EC3 share several mesenchymal-related enriched pathways with TGFB2-affected genes for EC4, including actin cytoskeleton organization (GO:0030036; p-value 4.4 × 10<sup>–7</sup>), NABA CORE MATRISOME (M5884; p-value 2.8 × 10<sup>–7</sup>), and ECM organization (R-HSA-1474244; p-value 5.4 × 10<sup>–7</sup>). TGFB2-attenuated transcripts unique to EC3 were enriched in platelet activation (GO:0030168; p-value 1.4 × 10<sup>–4</sup>) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><p>Most transcripts affected in EC3 were responsive to IL1B (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Importantly, several EC3 genes differentially expressed with IL1B were also affected with siERG (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). IL1B-affected transcripts in EC3 are not enriched in mesenchymal-like pathways (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). However, EC3 IL1B-attenuated genes are enriched in blood vessel development (GO:0032502; p-value 5.1 × 10<sup>–11</sup>), indicating that this perturbation still has anti-endothelial effects (<xref ref-type="fig" rid="fig4">Figure 4C</xref>).</p><p>Most genes significantly affected by perturbations in EC1 and EC2 were responsive to siERG, likely due to their more endothelial-like phenotypes compared to EC3 and EC4 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). siERG-affected genes in EC1 and EC2 were enriched in COVID-19 adverse outcome pathway (<xref ref-type="bibr" rid="bib93">Zhang et al., 2022</xref>) (WP4891; p-values 5 × 10<sup>–9</sup> and 8.3 × 10<sup>–5</sup>, for EC1-2, respectively) and AGE-RAGE signaling in diabetes (<xref ref-type="bibr" rid="bib22">Deng et al., 2020</xref>) (hsa04933; p-values 8.9 × 10<sup>–16</sup> and 1.9 × 10<sup>–20</sup>, respectively), while EC3 siERG-perturbed genes are enriched with a unique metabolic profile demonstrated by enrichment in monosaccharide metabolic process (GO:0005996; p-value 1 × 10<sup>–6</sup>), carbohydrate metabolic process (GO:0005975; p-value 6.6 × 10<sup>–7</sup>), and aerobic glycolysis (WP4629; p-value 4.1 × 10<sup>–5</sup>) (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). In contrast, EC4 siERG-induced genes are enriched in positive regulation of angiogenesis (GO:0045766; p-value 4.5 × 10<sup>–6</sup>), a function normally impaired in <italic>ERG</italic>-depleted ECs (<xref ref-type="fig" rid="fig4">Figure 4D</xref>; <xref ref-type="bibr" rid="bib26">Fish et al., 2017</xref>).</p><p>Due to the role that ERG plays in inhibiting NF-KB-dependent inflammation in vitro and in vivo (<xref ref-type="bibr" rid="bib74">Sperone et al., 2011</xref>), we set out to characterize mutually exclusive and shared pathways between IL1B and siERG (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Importantly, siERG, but not IL1B-perturbed genes, involves several previously mentioned metabolic processes including carbohydrate metabolic process (GO:0005975; p-value 6.6 × 10<sup>–7</sup>), aerobic glycolysis (WP4629; p-value 4.1 × 10<sup>–5</sup>), and monosaccharide metabolic process (GO:0005996; p-value 1 × 10<sup>–6</sup>). This suggests differences in the ability of ERG and IL1B to modify metabolism. Interestingly, IL1B but not siERG upregulated interferon signaling and viral responsive pathways (GO:0051607, p-value 1 × 10<sup>–37</sup>; R-HSA-913531, p-value 1 × 10<sup>–41</sup>). Shared IL1B- and siERG-upregulated genes were enriched in COVID-19 adverse outcome pathway (WP4891; p-value 1.9 × 10<sup>–9</sup>) (<xref ref-type="bibr" rid="bib93">Zhang et al., 2022</xref>). Shared IL1B- and siERG-attenuated genes are enriched in several processes involving ribosomal proteins, including ribosome, cytoplasmic (CORUM:306; p-value 3.3 × 10<sup>–7</sup>), cytoplasmic ribosomal proteins (WP477; p-value 5.3 × 10<sup>–7</sup>), and peptide chain elongation (R-HSA-156902; p-value 5.9 × 10<sup>–7</sup>) (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). This finding indicates that the downregulation of ribosomal genes is a hallmark of inflammatory and <italic>ERG</italic>-depleted endothelium. Altogether, these data demonstrate the heterogeneity in EC subtype response to pro-EndMT perturbations.</p></sec><sec id="s2-5"><title>In vitro EC EndMT models reorganize epigenetic landscapes with subtype specificity</title><p>To gain insight into gene regulatory mechanisms responsible for EC subtype transcriptional responses to IL1B, TGFB2, and siERG, we compared the effects of these perturbations on chromatin accessibility. Across all three treatments, we identified 4034 DARs (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1j</xref>, ‘Materials and methods’). The majority of DARs for EC1 and EC2 were responsive to siERG, while the majority of DARs for EC3 were responsive to IL1B (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1j</xref>). Interestingly, the epigenetic landscape of EC4 differs from its transcriptional response, insofar as most peaks were responsive to IL1B (not TGFB2) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1j</xref>). To inform the TFs likely bound to differentially accessible regulatory elements, motif enrichment analysis was performed (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B–D</xref>). Several distinct TF motifs were enriched across EC subtypes. For IL1B, we observed enrichment in KLF15 (adjusted p-value 5 × 10<sup>–10</sup>) (Kruppel-like factor 15) in EC2 alone (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). siERG-induced peaks showed subtype-specific motif enrichments, including TWIST1 (adjusted p-value 2.5 × 10<sup>–22</sup>) (twist family bHLH transcription factor 1), HAND2 (adjusted p-value 2.3 × 10<sup>–19</sup>) (heart and neural crest derivatives expressed 2) for EC1, RELA (adjusted p-value 9.5 × 10<sup>–20</sup>) (RELA proto-oncogene, NF-KB subunit) for EC2, and CEBPD (adjusted p-value 1.6 × 10<sup>–29</sup>) for EC3 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). Minimal motif enrichment was observed with siERG for EC4.</p><p>We also found several TF motifs enriched across more than one EC subtype upon perturbation. IL1B-affected peaks gained in EC1 and EC2 shared enrichments for TFDP1 (adjusted p-value 1.3 × 10<sup>–4</sup> and 9 × 10<sup>–4</sup> for EC1 and EC2, respectively) (transcription factor Dp1) and ZBTB14 motifs (adjusted p-value 2.2 × 10<sup>–4</sup> and 2 × 10<sup>–8</sup>, respectively) (zinc finger and BTB domain containing 14). IL1B-induced peaks in EC3 and EC4 shared enrichment for CEBPD (adjusted p-value 4.4 × 10<sup>–73</sup> and 1.6 × 10<sup>–33</sup> for EC3 and EC4, respectively) and CEBPG motifs (adjusted p-value 5.4 × 10<sup>–45</sup> and 7.1 × 10<sup>–18</sup>, respectively) (CCAAT enhancer binding protein delta and gamma) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). TGFB2-affected peaks in EC1, EC2, and EC3 shared enrichment for ZBTB14 (adjusted p-values 6.8 × 10<sup>–31</sup>, 5.1 × 10<sup>–12</sup>, and 2 × 10<sup>–8</sup>, for EC1, EC2, and EC3, respectively) while TGFB2-induced peaks in EC3 and EC4 shared enrichment for the SMAD5 motif (adjusted p-value 7.4 × 10<sup>–6</sup> and 4.2 × 10<sup>–11</sup>, for EC3 and EC4, respectively) (SMAD family member 5) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Taken together, while several enriched motifs are shared across EC subtypes, divergent epigenetic landscapes are also induced with pro-EndMT perturbations. We therefore conclude that different transcriptional responses to these perturbations across EC subtypes are elicited by distinct TFs, including members of families of the KLF, TWIST, HAND, p65, and CEBP families.</p></sec><sec id="s2-6"><title>Meta-analysis of ex vivo human atherosclerotic plaque snRNA-seq datasets</title><p>To understand the diversity of ECs in human atherosclerotic plaques and evaluate their relationships to our in vitro system, we performed a meta-analysis of data from recent publications that utilized scRNA-seq from human atherosclerotic lesions (<xref ref-type="bibr" rid="bib63">Pan et al., 2020</xref>; <xref ref-type="bibr" rid="bib2">Alsaigh et al., 2022</xref>; <xref ref-type="bibr" rid="bib17">Chowdhury et al., 2022</xref>; <xref ref-type="bibr" rid="bib87">Wirka et al., 2019</xref>; accessions in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1k</xref>). We identified 24 diverse clusters among 58,129 cells after integration of 17 different coronary and carotid samples (<xref ref-type="fig" rid="fig5">Figure 5A</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1l</xref>). Clusters were annotated using a combinatorial approach including canonical marker genes, CIPR (<xref ref-type="bibr" rid="bib24">Ekiz et al., 2020</xref>), and the original publications (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Clusters were annotated as T-lymphocytes, natural killer T-cells, ECs, macrophages, VSMCs, fibroblasts, B-lymphocytes, basophils, neurons, and plasmacytoid dendritic cells (PDCs) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). We find the greatest proportion of cells belonging to each major cell type derive from carotid arteries, except for neurons that derive exclusively from coronary arteries, and PDCs that derive exclusively from carotid arteries (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B and C</xref>). Expected pathway enrichments are observed for annotated cell types, including NABA CORE MATRISOME (M5884; p-value 4.8 × 10<sup>–41</sup>) for fibroblasts, blood vessel development (GO:0001568; p-value 5.6 × 10<sup>–33</sup>) for ECs, and actin cytoskeleton organization (GO:0030036; p-value 1.3 × 10<sup>–15</sup>) for VSMCs (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D–G</xref>). These observations support the diverse composition of human atherosclerotic lesions.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Endothelial cells (ECs) from ex vivo human atherosclerotic plaques show two major populations.</title><p>(<bold>A</bold>) scRNA-seq UMAP of different cell subtypes across 17 samples of ex vivo human atherosclerotic plaques. (<bold>B</bold>) Dot plot of top markers for each cell type. (<bold>C</bold>) Heatmap of pathway enrichment analysis (PEA) results generated from submitting 200 differentially expressed genes (DEGs) between endothelial cells 1 (Endo1) and endothelial cells 2 (Endo2). Rows (pathways) and columns (cell subtypes) are clustered based on -Log<sub>10</sub>(P). (<bold>E</bold>) Heatmap displaying expression of genes belonging to ribosome cytoplasmic pathway for Endo1 and Endo2.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Characterization of RNA-seq profiles from ex vivo arterial samples.</title><p>(<bold>A</bold>) UMAP displaying original clusters formed from scRNA-seq data taken from 17 samples across four studies of human ex vivo atherosclerotic plaques. Colors denote different clusters. (<bold>B</bold>) UMAP from (<bold>A</bold>). Colors denote anatomical location from which cells derived. (<bold>C</bold>) Stacked bar graph showing the distribution of anatomic location (red denoting carotid, blue denoting coronary arteries) from which cells derived. (<bold>D</bold>) Heatmap of pathway enrichment analysis (PEA) results from submitting top 100 differentially expressed genes (DEGs) (by ascending p-value) between ex vivo cell types. Rows (pathways) and columns (cell subtypes) are clustered based on -Log<sub>10</sub>(P). (<bold>E</bold>) PEA of the top 100 DEGs (by ascending p-value) for plasmacytoid dendritic cells (PDCs). (<bold>F</bold>) PEA of the top 100 DEGs (by ascending p-value) for neurons. (<bold>G</bold>) PEA of the top 100 DEGs (by ascending p-value) for basophils. Adjusted p-value&lt;0.05 for DEGs submitted in (<bold>D–G</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Violin plots displaying upregulation of several EndMT markers in Endo2, compared to Endo1, including <italic>FN1</italic>, <italic>BGN</italic>, <italic>COL8A1</italic>, <italic>ELN</italic>, <italic>CCN1</italic>, <italic>FBLN5</italic>.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig5-figsupp2-v1.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Cross comparisons between in vitro and ex vivo RNA-based module scores.</title><p>(<bold>A</bold>) Feature plots for each ex vivo module score across in vitro cells. Briefly, ex vivo module scores are generated using top marker genes for each ex vivo cell subtype. The Seurat function AddModuleScore is used to score each cell for visualization. (<bold>B</bold>) Violin plots displaying endothelial cells 1 (Endo1), endothelial cells 2 (Endo2), and vascular smooth muscle cell 5 (VSMC5) module scores for each perturbation across in vitro EC1–4. (<bold>C</bold>) Feature plots displaying distribution of Endo1 (red) versus Endo2 (green) module scores across in vitro cells. (<bold>D</bold>) Feature plots displaying distribution of Endo1 (red) versus VSMC5 (green) module scores across in vitro cells. (<bold>E</bold>) Feature plots displaying distribution of Endo2 (red) versus VSMC5 (green) modules scores across in vitro cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig5-figsupp3-v1.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 4.</label><caption><title>Heatmap and pathway analysis for marker genes of the VSMC5 ex vivo cluster.</title><p>(<bold>A</bold>) Heatmap displaying average expression of VSMC5 maker genes (black arrow) across in vitro and ex vivo datasets. Rows (genes) and columns (cell subtypes) are clustered based on average expression for each given gene. (<bold>B</bold>) Pathway enrichment analysis (PEA) of the top 200 genes for VSMC5 (adjusted p-value&lt;0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig5-figsupp4-v1.tif"/></fig><fig id="fig5s5" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 5.</label><caption><title>Breakdown of ex vivo module scores across in vitro clusters and sample identity.</title><p>(<bold>A</bold>) Violin plots of ex vivo Endo1 module scores across EC1–4. (<bold>B</bold>), Violin plots of ex vivo Endo2 module scores across EC1–4. (<bold>C</bold>) Violin plots of ex vivo VSMC5 module scores across EC1–4. Adjusted p-value for (<bold>A–C</bold>) generated using Wilcoxon rank sum test with continuity correction by setting the alternative hypothesis to ‘two.sided’.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig5-figsupp5-v1.tif"/></fig></fig-group><p>We evaluated what pathways distinguished the endothelial cells 1 (Endo1) and endothelial cells 2 (Endo2) subtypes from our ex vivo meta-analysis (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). We found Endo2 has an EndMT-related phenotype, with enrichment in mesenchymal pathways including NABA MATRISOME ASSOCIATED (M5885; p-value 1.6 × 10<sup>–14</sup>), ECM organization (R-HSA-1474244; p-value 6 × 10<sup>–17</sup>), skeletal system development (GO:0001501; p-value 3.4 × 10<sup>–13</sup>), and network map of SARS-CoV-2 signaling pathway (<xref ref-type="bibr" rid="bib93">Zhang et al., 2022</xref>) (WP5115; p-value 1.3 × 10<sup>–11</sup>) (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). Additionally, we observe enrichment for inflammatory pathways in Endo2 including prostaglandin synthesis and regulation (WP98; p-value 1.2 × 10<sup>–7</sup>), and complement and coagulation cascades (hsa04610; 1 × 10<sup>–10</sup>) (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>; <xref ref-type="bibr" rid="bib66">Ricciotti and FitzGerald, 2011</xref>; <xref ref-type="bibr" rid="bib46">Levi et al., 2004</xref>). On the contrary, Endo1 was highly enriched in multicellular organismal homeostasis (GO:0048871; p-value 3.3 × 10<sup>–8</sup>) and lowly enriched in mesenchymal pathways (M5885; p-value 1 × 10<sup>–3</sup>; no enrichment for R-HSA-1474244, GO:0001501, or WP5115), indicating a canonical EC phenotype (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). Interestingly, Endo1, but not Endo2, is highly enriched in ribosome, cytoplasmic pathway (CORUM:306; p-value 9.3 × 10<sup>–96</sup>), and TRBP containing complex (CORUM:5380; DICER, RPL7A, EIF6, MOV10 and subunits of the 60S ribosomal particle; p-value 1.5 × 10<sup>–22</sup>), suggesting a potential protective role for this complex along with ribosomal gene expression (<xref ref-type="bibr" rid="bib61">Ni and Buszczak, 2023</xref>; <xref ref-type="bibr" rid="bib78">Suárez et al., 2007</xref>). The depletion of these pathways may serve as a hallmark of activated endothelium (<xref ref-type="fig" rid="fig5">Figure 5C–E</xref>). We interpret these results to suggest that Endo1 is a classical endothelial state, while Endo2 appears to be characterized by ECM production and possibly indicate EndMT. This interpretation is further corroborated by evidence of upregulation of several classical EndMT markers in Endo2, including <italic>FN1</italic>, <italic>BGN</italic>, <italic>COL8A1</italic>, <italic>ELN</italic>, <italic>CCN1</italic>, and <italic>FBLN5</italic> (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>; <xref ref-type="bibr" rid="bib42">Krizbai et al., 2015</xref>; <xref ref-type="bibr" rid="bib96">Zhao et al., 2021b</xref>; <xref ref-type="bibr" rid="bib64">Pinto et al., 2018</xref>; <xref ref-type="bibr" rid="bib75">Stenmark et al., 2016</xref>; <xref ref-type="bibr" rid="bib30">Gole et al., 2022</xref>; <xref ref-type="bibr" rid="bib45">Lee et al., 2008</xref>).</p></sec><sec id="s2-7"><title>Ex vivo-derived module score analysis reveals differences among in vitro EC subtypes and EndMT stimuli</title><p>To directly evaluate the relationships between the ex vivo and in vitro cell subpopulations, we utilized module scores. These quantitative scores are based on the sum of ex vivo marker genes across each cluster and were used to evaluate similarity to each in vitro cell subcluster. Unexpectedly, the ex vivo cluster that consistently generated the greatest module scores for in vitro ECs is the VSMCs cluster 5 (VSMC5) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3A</xref>). VSMC5 bridges the EC to SMC and fibroblast clusters in the ex vivo analysis (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Marker genes of VSMC5 are expressed across ex vivo and in vitro clusters (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4A</xref>) and include important regulators of ECM, such as <italic>BGN</italic>, <italic>VCAN</italic>, <italic>FN1</italic>, as well as several collagen genes (<italic>COL1A1</italic>, <italic>COL1A2</italic>, <italic>COL3A1</italic>, <italic>COL6A1</italic>) (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4A and B</xref>). VSMC5 marker transcripts also include several lncRNAs and mitochondrial transcripts (<italic>CARMN</italic>, <italic>MALAT1</italic>, <italic>NEAT1; MT-ATP6</italic>, <italic>MT-ND4</italic>, and <italic>MT-CYB</italic>) (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4A</xref>). Ex vivo Endo1 and Endo2 module scores are the second highest scoring across in vitro clusters. Cells scoring high for Endo1 are concentrated in the in vitro EC1 cluster, while cells scoring high in Endo2 are concentrated to the in vitro EC3 locale (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3B–E</xref>). This supports that EC3 is a more activated subtype than EC1. Finally, among in vitro cells, those with highest VSMC5 module scores are concentrated in EC4, underscoring that EC4 is a more mesenchymal sub-phenotype in vitro (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3B–E</xref>).</p><p>We stratify these analyses by pro-EndMT treatment and find greater VSMC5 module scores with TGFB2 treatment versus control for EC3 (adjusted p-value=0.001) and EC4 (adjusted p-value=9.9 × 10<sup>–15</sup>) (<xref ref-type="fig" rid="fig5s5">Figure 5—figure supplement 5A–C</xref>). However, there is no difference in VSMC5 module scores for EC1-2 between control and TGFB2 treatment, suggesting these subtypes are resistant to transcriptional changes by TGFB2 exposure (i.e., EC1-2). This is in contract to the more mesenchymal-like EC (i.e., EC3-4) subtypes, which are more responsive to TGFB2 (<xref ref-type="fig" rid="fig5s5">Figure 5—figure supplement 5A–C</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1l and m</xref>). We observe siERG lowers Endo1 scores across all EC subtypes (adjusted p=9.9 × 10<sup>–15</sup> for EC1-4), indicating <italic>ERG</italic> depletion decreases endothelial-likeness across all EC subtypes (<xref ref-type="fig" rid="fig5s5">Figure 5—figure supplement 5A–C</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1m and n</xref>). Moreover, siERG increases VSMC5 scores for EC2 (adjusted p=2.8 × 10<sup>–9</sup>) and EC3 (adjusted p-value 0.04), indicating siERG elicits activated and mesenchymal characteristics (<xref ref-type="fig" rid="fig5s5">Figure 5—figure supplement 5A–C</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1m and n</xref>).</p></sec><sec id="s2-8"><title>EC subtype is a major determinant in modeling cell states observed in atherosclerosis</title><p>In addition to module score analysis, we applied a complementary approach to quantitatively relate in vitro EC subtypes and pro-EndMT perturbations to ex vivo cell types. We calculate average expression profiles for all major cell populations in both ex vivo and in vitro datasets and examine the comprehensive pairwise relationship among populations with hierarchical clustering using Spearman Correlation (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). All in vitro transcripts significantly regulated across all pro-EndMT perturbations at 5% false discovery rate (FDR) (<xref ref-type="bibr" rid="bib5">Benjamini and Hochberg, 1995</xref>) are used in this analysis, although several additional means to select transcripts showed similar results. This analysis reveals three major observations. First, in vitro EC4 cells are most like mesenchymal ex vivo cell types, including VSMCs and fibroblasts (indicated by the yellow block of correlations in the bottom left of the heatmap in <xref ref-type="fig" rid="fig6">Figure 6A</xref>). Second, in vitro EC1, EC2, and EC3 are most like ex vivo Endo1 and Endo2 populations, especially among the siSCR and 7-day control cells. Moreover, cells in the siSCR condition in EC1 are most like ex vivo Endo1, reinforcing that these two populations are the most canonically ‘healthy’ endothelial populations. Third, while pro-EndMT perturbations did elicit variation in how similar in vitro ECs resembled ex vivo transcriptomic signatures, these effects are secondary to which subtype the cells belonged (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Taken together, these findings underscore that EC subtype, versus perturbation, is a greater determinant of similarity to ex vivo cell types.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Endothelial cell (EC) subtype is a major determinant in the ability to recapitulate ‘omic profiles seen in atherosclerosis.</title><p>(<bold>A</bold>) Heatmap displaying average expression between in vitro perturbation-subtype combinations and ex vivo cell subtypes using all up- and downregulated genes between IL1B, TGFB2, or siERG versus respective controls. Spearman correlation was used as the distance metric. Rows (in vitro EC subtypes) and columns (ex vivo cell subtypes) are clustered using all significant genes (adjusted p-value&lt;0.05) induced and attenuated across all in vitro EC subtypes for each perturbation versus its respective control. (<bold>B</bold>) Heatmap of coronary artery disease (CAD)-associated single-nucleotide polymorphism (SNP) enrichments across in vitro EC subtypes and perturbation–subtype combinations. Rows (EC subtypes and perturbation-subtype combinations) are clustered using -Log<sub>10</sub>(P) for enrichment in significant CAD-associated SNPs (p-value&lt;5 × 10<sup>–8</sup>). Note that ‘diff’ represents peaks common to more than one EC subtype; it is found by subtracting EC1–5 subtype-specific peaks from the entire in vitro peak set (termed ‘panEC’). (<bold>C</bold>) Coverage plots displaying links for <italic>COL4A1</italic>/<italic>COL4A2</italic> genes to EC4-specific peaks, including one overlapping with CAD-associated SNP rs9515203. (<bold>D</bold>) Coverage plot showing links for <italic>PECAM1</italic> gene to EC4-specific peaks, including one overlapping with CAD-associated SNP rs1108591. (<bold>E</bold>) Coverage plot showing links for <italic>BMP6</italic> gene to EC4-specific peaks, including one overlapping with CAD-associated SNP rs6597292.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Pathway enrichment analysis (PEA) of significant (p-value&lt;0.05) EC4-linked genes that overlap with significant (p-value&lt;10<sup>–8</sup>) coronary artery disease (CAD)-associated single-nucleotide polymorphism (SNP).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-91729-fig6-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-9"><title>CAD-associated genetic variants are enriched across EC subtype epigenomes</title><p>Genetic predisposition to CAD is approximately 50% heritable with hundreds to thousands of genetic loci supposed to be involved in shaping an individual’s propensity for disease (<xref ref-type="bibr" rid="bib23">Drobni et al., 2022</xref>; <xref ref-type="bibr" rid="bib55">McPherson and Tybjaerg-Hansen, 2016</xref>). Most CAD-associated variants are not protein coding, suggesting that they perturb cellular function through gene regulatory functions. We therefore asked whether the open chromatin regions in this in vitro dataset coincided with locations of single-nucleotide polymorphisms (SNPs) reported in the latest CAD meta-GWAS analysis from the Millions Veterans Project, which includes datasets from CARDIoGRAMplusC4D 1000G study, UK Biobank CAD study, and Biobank Japan (<xref ref-type="bibr" rid="bib79">Tcheandjieu et al., 2022</xref>). We found significant enrichment in CAD-associated SNPs for the complete set of accessible regions across all EC subtypes (termed ‘panEC’; adjusted p-value 1.5e × 10<sup>–93</sup>; odds ratio [OR] = 1.8; <xref ref-type="fig" rid="fig6">Figure 6B</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1o and p</xref>) when comparing CAD SNPs exceeding the genome-wide significance threshold of p&lt;5 × 10<sup>–8</sup> versus nonsignificant SNPs (‘Materials and methods). Among accessible regions unique to EC subtypes, EC4 shows the greatest enrichment (adjusted p-value 7.85 × 10<sup>–6</sup>; OR = 1.74). Additionally, EC2 is also enriched for CAD SNPs (adjusted p-value 6.3 × 10<sup>–8</sup>; OR = 2.15), supporting a role for proliferative ECs in CAD. Of all accessible regions influenced by pro-EndMT perturbations, siERG and TGFB2 sets are most enriched for CAD variants (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1o and p</xref>).</p><p>The measurement of both gene expression and DNA accessibility in the same cell enables testing for direct correlation, or ‘links’, between accessibility of noncoding DNA elements and gene expression of their potential regulatory targets (i.e., gene promoters). This is achieved by testing for correlation between DNA accessibility and the expression of a nearby gene across single cells (<xref ref-type="bibr" rid="bib77">Stuart et al., 2021</xref>; <xref ref-type="bibr" rid="bib11">Cao et al., 2018</xref>). Focusing on EC4, we search for EC4-specific sites of correlated chromatin accessibility and linked target gene expression. Upon restricting linked peaks overlapping CAD SNPs, we identify 81 significant SNP-peak-gene trios (p&lt;0.05) representing 46 unique genes with specific activity in EC4 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1q</xref>). We submit the 46 unique genes to Metascape (<xref ref-type="bibr" rid="bib98">Zhou et al., 2019</xref>) and observe enrichment in EndMT-related pathways including blood vessel development (GO:0001568; p-value 2.1 × 10<sup>–10</sup>), crosslinking of collagen fibrils (R-HSA-2243919; p-value 1.4 × 10<sup>–8</sup>), and canonical and non-canonical TGFB signaling (WP3874; p-value 2.2 × 10<sup>–6</sup>) (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Literature review of this gene list further confirms several linked EC4-restricted genes associated with cardiovascular disease, including <italic>COL4A1</italic>, <italic>COL4A2</italic>, <italic>PECAM1, DSP</italic>, and <italic>BMP6</italic> (<xref ref-type="fig" rid="fig6">Figure 6C–E</xref>; <xref ref-type="bibr" rid="bib48">Liu et al., 2019</xref>; <xref ref-type="bibr" rid="bib91">Yang et al., 2016</xref>; <xref ref-type="bibr" rid="bib88">Woodfin et al., 2007</xref>).</p><p>Altogether, these data underscore that common genetic variation influences individual propensities for CAD through ECM-organizing functions evidenced by the EC4 phenotype.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The major goals of this study were fourfold: (1) quantitatively assess molecular heterogeneity of cultured HAECs in vitro, (2) evaluate and compare molecular changes elicited by EC-activating perturbations at single-cell resolution, (3) assess similarities between in vitro and ex vivo EC signatures to inform the extent to which in vitro models recapitulate ex vivo biology, and (4) investigate how heterogeneous EC populations are enriched for genetic associations to CAD. The findings for each of these goals are discussed below, along with important implications and questions arising from this work.</p><p>The multiomic single-cell profiles of 15,220 cells cultured in vitro from six individuals enabled the discovery of five EC subpopulations, named EC1, EC2, EC3, EC4, and EC5. Except for EC5, EC subpopulations were comprised of cells from multiple donors and perturbations, which lends credence to the reproducibility of these biological states. The loosely defined phenotypes, based on pathway enrichment analysis, were healthy/angiogenic for EC1, proliferative for EC2, activated for EC3, and mesenchymal for EC4. Angiogenic (<xref ref-type="bibr" rid="bib47">Li et al., 2019</xref>; <xref ref-type="bibr" rid="bib36">Kalluri et al., 2019</xref>; <xref ref-type="bibr" rid="bib95">Zhao et al., 2021a</xref>), proliferative (<xref ref-type="bibr" rid="bib80">Tombor et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Rodor et al., 2022</xref>), and mesenchymal (<xref ref-type="bibr" rid="bib80">Tombor et al., 2020</xref>) ECs have been previously reported in the literature. The three activating perturbations (TGFB2, IL1B, siERG) had markedly unique effects on different EC subclusters, highlighting the fact that in vitro systems contain populations of discrete cell subtypes, or states, that respond divergently to even reductionistic experimental conditions. Implications of such heterogeneity include both a need to elucidate what factors dictate treatment responsiveness, as well as experimental design and data interpretation that considers heterogeneity of response. The exact origin of EC heterogeneity observed in this study is unknown. We consider it likely that EC1 EC2, EC3, and EC4 subpopulations, which were populated by most donors, date back to the original isolation of ECs from aortic trimmings, implying that different states were preserved across passage in the culture conditions. However, we cannot exclude the possibility that some of the subpopulations have expanded since seeding of the cultures. If that were the case, EC1, EC2, EC3, and EC4 represent reproducible cell states consequent to primary culture of arterial cells. In fact, the limited correlation with ex vivo data supports this interpretation. Future studies will be required to delineate the exact source of heterogeneity in these systems.</p><p>In this study, we set out to elucidate whether the mesenchymal phenotype of EC4 was an end-stage result of EndMT and whether TGFB2, IL1B, and/or siERG would increase the proportion of cells in EC4. As shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>, this hypothesis was incorrect, and the only cluster with a modest increase in cell proportions upon stimulation was EC3. Moreover, while the percent of cells in EC3 increased with TGFB or IL1B, they decreased in EC4, suggesting trans-differentiation from EC4 into EC3 with these perturbations. We cannot exclude the possibility that EC3 is an EndMT cluster, although we would have expected more significant deviation from clusters EC1 and EC2. It is also possible that the postmortem state experienced by aortic explants prior to EC isolation could induce changes in the ECs, or that the duration and doses of perturbations chosen were not sufficient to elicit complete EndMT. While the duration and doses employed in our study were established based on literature reports reporting EndMT phenotypes (<xref ref-type="bibr" rid="bib52">Maleszewska et al., 2013</xref>; <xref ref-type="bibr" rid="bib59">Nagai et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Medici et al., 2011</xref>), EndMT was quantified by expression of only a few marker genes rather than complete transcriptomic analysis. This raises an important conclusion of our study, which is that EndMT is not well-defined molecularly and it remains possible that several different molecular profiles may each represent variant flavors of EndMT.</p><p>We found that TGFB2, IL1B, and siERG have many distinct effects on EC molecular profiles (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4</xref>). In general, TGFB2 elicits a greater transcriptomic and epigenomic response in the mesenchymal EC subtype, EC4, while siERG and IL1B regulate the greatest numbers of shared transcripts and chromatin regions in more endothelial clusters EC1, EC2, and EC3. One interpretation for this finding is that IL1B treatment and depletion of <italic>ERG</italic> directly affect rewiring transcription in ECs while TGFB2 may affect other cell types in the vascular wall (or culture plate) that in turn affect ECs through paracrine interactions. Part of the similarities between IL1B and siERG responses may be explained by the fact that <italic>ERG</italic> depletion increases IL1B production (<xref ref-type="bibr" rid="bib34">Hogan et al., 2017</xref>).</p><p>A major question raised by this work is the origin of cells in the mesenchymal cluster EC4. We originally hypothesized this cluster was the result of EndMT, which led to our investigations as to whether we could leverage EndMT-promoting exposures (IL1B, TGFB2, siERG) in vitro observe an expansion of treated cells in the EC4 population. To our surprise, the EC4 population did not expand. If anything, these exposures reduced the proportion of cells in ECs (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Nonetheless, it remains a possibility that EC4 represents cells that had undergone EndMT in vivo prior to culture and that the exposures we presented in vitro were not sufficient to elicit a complete EndMT transition. Another viable hypothesis is that cells in EC4 are of SMC origin and have persisted in culture alongside their EC counterparts. Cells used in this study were isolated by luminal collagenase digestion of explanted aortic segments and were tested at early passage for EC phenotypic markers including VWF expression, cobblestone morphology, and uptake of acetylated LDL. Notably, these rigorous metrics to ensure pure EC isolation occurred prior to our group’s studies. In addition, if some of the isolated cells had undergone EndMT in vivo prior to isolation, it would be nearly impossible to distinguish their cell of origin after isolation since their collective molecular phenotypes would appear as an SMC. Without lineage tracing, which is currently not possible in human tissue explants, it would not be possible to distinguish cell origin. Nonetheless, this remains an important issue that is the subject of ongoing investigations. What we can confidently discern from these data is that these distinct cell subpopulations respond differently to the disease-relevant exposures of IL1B, TGFB2, and ERG depletion.</p><p>The current study sought to evaluate similarities and differences between in vitro primary cultures of HAECs to ex vivo single-cell signatures of cells from human lesions. First, we leveraged transcriptomic profiles from clusters in the scRNA meta-analysis of human lesions and evaluated each in vitro cluster using a module score (<xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>). The three ex vivo clusters with greatest similarity to in vitro clusters were Endo1, Endo2, and VSMC5. Pathway enrichment analysis suggested that the ex vivo Endo1 cluster is close to the classic ‘healthy’ EC state relative to Endo2, which returned pathway enrichments consistent with activated endothelium (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). Interestingly, Endo2 is depleted in ribosome transcripts as well as transcripts in the Dicer complex (<xref ref-type="fig" rid="fig5">Figure 5C–E</xref>), which may serve as hallmarks of dysregulated endothelium in vivo. VSMC5 is an interesting ex vivo cluster insofar as it spans the endothelial, fibroblast, and VSMC clusters (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) and is enriched for genes in actin cytoskeleton, extracellular matrix organization, and more (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>). In vitro EC1, EC2, and EC3 score generally greater in Endo1 and Endo2 relative to the more mesenchymal EC4 (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). Consistent with the intent of the pro-EndMT treatments, they generally decrease Endo1 and Endo2 scores and increase VSMC5 scores. However, these effects are unexceptional in comparison to effects of EC subtype. In addition to module scores, we also utilized unsupervised clustering of Spearman correlation coefficients across ex vivo and in vitro average gene expression profiles, finding again that EC1, EC2, and EC3 are more like Endo1 and Endo2 and EC4 is more like VSMCs (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). As expected, the control (siSCR) cells are most correlated to healthy Endo1 transcriptomes; however, the correlation coefficient achieved is modest, at rho = 0.56. We cannot exclude the possibility that the moderate correlation coefficient observed between in vitro and ex vivo ECs may be explained by anatomic differences (i.e., aortic versus coronary and carotid arteries). While reinforcing that in vitro cell cultures best resemble ECs isolated ex vivo, regardless of perturbation, this finding accentuates how different cultured cells are and paves the way for quantitatively evaluating and improving in vitro models.</p><p>Finally, GWAS have established that hundreds of independent common genetic variants in human populations affect risk for CAD, yet discovering the causal mechanisms remains a major challenge given that most of the risk is in non-coding regions of the genome. One approach to prioritize causal variants in regulatory elements is through integration of open chromatin regions from the cell type and states of interest followed by expression quantitative trait loci (eQTL) or other linking evidence to target gene (<xref ref-type="bibr" rid="bib76">Stolze et al., 2020</xref>; <xref ref-type="bibr" rid="bib81">Toropainen et al., 2022</xref>). In the current study, we find significant enrichment for CAD-risk variants in open chromatin regions across the entire dataset (‘panEC’) as well as specifically for EC2 and EC4 subpopulations (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1o-q</xref>). While EC3 was found to be more sensitive to perturbations in our in vitro experiments, we did not expect to see CAD-related SNPs enriched in EC3 because plasticity does not necessarily imply a pathological process. Moreover, while EC3 and EC4 both have mesenchymal phenotypes, EC3 may represent a reversible state that is lacking in EC4. This hypothesis would explain the enrichment of EC4, but not EC3, in CAD-related SNPs.</p><p>Taken together, these data emphasize the value in multimodal datasets in human samples for prioritizing disease-associated SNPs and mechanisms.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Tissue procurement and cell culture</title><p>Primary HAECs were isolated from eight deidentified deceased heart donor aortic trimmings (belonging to three females and five males of Admixed Americans, European, and East Asian ancestries) at the University of California Los Angeles Hospital as described previously (<xref ref-type="bibr" rid="bib60">Navab et al., 1988</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>). The only clinically relevant information collected for each donor was their genotype (see ‘Genotyping and multiplexing cell barcodes for donor identification‘). HAECs were isolated from the luminal surface of the aortic trimmings using collagenase and identified by Navab et al. using their typical cobblestone morphology, presence of Factor VIII-related antigen, and uptake of acetylated LDL labeled with 1,1′-dioctadecyl-1–3,3,3′,3′-tetramethyl-indo-carbocyan-ine perchlorate (Di-acyetl-LD) (<xref ref-type="bibr" rid="bib60">Navab et al., 1988</xref>). Cells were grown in culture in M-199 (Thermo Fisher Scientific, Waltham, MA, MT-10-060-CV) supplemented with 1.2% sodium pyruvate (Thermo Fisher Scientific, Cat# 11360070), 1% 100× Pen Strep Glutamine (Thermo Fisher Scientific, Cat# 10378016), 20% fetal bovine serum (GE Healthcare, Hyclone, Pittsburgh, PA), 1.6% Endothelial Cell Growth Serum (Corning, Corning, NY, Cat# 356006), 1.6% heparin, and 10 μl/50 ml Amphotericin B (Thermo Fisher Scientific, Cat# 15290018). Mycoplasma testing was not carried out on the cells used. HAECs at low passage (passages 3–6) were treated prior to harvest every 2 d for 7 d with either 10 ng/ml TGFB2 (Thermo Fisher Scientific, Cat# 302B2002CF), IL1B (Thermo Fisher Scientific, Cat# 201LB005CF), or no additional protein, or two doses of small interfering RNA for ERG locus (siERG; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1r</xref>), or randomized siRNA (siSCR; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1r</xref>). Donors 7 and 8 were treated prior to harvest for 6 hr with either 1 ng/ml IL1B, or no additional protein, and included in the dataset during integration to generate the original UMAP (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), but not used for the purposes of downstream analyses in this study (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>). All HAECs used were authenticated based on morphology, gene expression profiles indicative of ECs, and donor genotypes. No commercially available cell lines were analyzed in this study.</p></sec><sec id="s4-2"><title>siRNA knockdown, qPCR, and western blotting</title><p>Knockdown of ERG was performed as previously described (<xref ref-type="bibr" rid="bib34">Hogan et al., 2017</xref>) using 1 nM siRNA oligonucleotides in OptiMEM (Thermo Fisher Scientific, Cat# 11058021) with Lipofectamine 2000 (Thermo Fisher Scientific, Cat# 11668030). Transfections were performed in serum-free media for 4 hr, then cells were grown in full growth media for 48 hr. All siRNAs and qPCR primers used in this study are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1r</xref>. Transfection efficiency for the siRNAs utilized in this study was verified using qPCR 7 d after transfection (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A</xref>). Protein knockdown is shown 2 d after transfection using the same siRNAs from a representative experiment (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>). Antibodies used included 1:1000 recombinant anti-ERG antibody (ab133264) and 1:5000 anti-histone H3 antibody (ab1791) (Abcam). Western blots were quantified using ImageJ (<xref ref-type="bibr" rid="bib73">Schneider et al., 2012</xref>).</p></sec><sec id="s4-3"><title>Nuclear dissociation and library preparation</title><p>Nuclei from primary cells were isolated according to 10X Genomics <italic>Nuclei Isolation for Single Cell Multiome ATAC+Gene Expression Sequencing</italic> Demonstrated Protocol (CG000365, Rev C) (<xref ref-type="bibr" rid="bib29">Genomics x, 2022b</xref>). Nuclei were pooled isolated with lysis buffer consisting of 10 mM Tris-HCl (pH 7.5, Invitrogen, Cat# 15567027), 10 mM NaCl (Invitrogen, Cat# AM9759), 3 mM MgCl<sub>2</sub> (Alfa Aesar, Cat# J61014), 0.1% Tween-20 (Thermo Fisher Scientific, Cat# 9005-64-5), 0.1% IGEPAL CA-630 (Thermo Fisher Scientific, Cat# J61055.AP), 0.01% Digitonin (Thermo Fisher Scientific, Cat# BN2006), 1% BSA (Sigma-Aldrich, Cat# A2153), 1 mM DTT (Thermo Fisher Scientific, Cat# 707265 ML), 1 U/μl RNase inhibitor (Sigma Protector RNase inhibitor; Cat# 3335402001), and nuclease-free water (Invitrogen, Cat# 10977015). The seven pooled samples were incubated on ice for 6.5 min with 100 μl lysis buffer and washed three times with 1 ml wash buffer consisting of 10 mM Tris–HCl, 10 mM NaCl, 3 mM MgCl<sub>2</sub>, 1% BSA, 0.1% Tween-20, 1 mM DTT, 1 U/μl RNase inhibitor, and nuclease-free water. Samples were centrifuged at 500 rcf for 5 min at 4°C, and the pellets were resuspended in chilled Diluted Nuclei Buffer consisting of 1× Nuclei Buffer (20×) (10X Genomics), 1 mM DTT (Thermo Fisher Scientific, Cat# 707265 ML), 1 U/μl RNase inhibitor, and nuclease-free water. The homogenate was filtered through a 40 μm cell strainer (Flowmi, Cat# BAH136800040) prior to proceeding immediately to 10X Chromium library preparation according to the manufacturer’s protocol (CG000338).</p></sec><sec id="s4-4"><title>Genotyping and multiplexing cell barcodes for donor identification</title><p>Genotyping of HAEC donors was performed as described previously (<xref ref-type="bibr" rid="bib76">Stolze et al., 2020</xref>). Briefly, IMPUTE2 (<xref ref-type="bibr" rid="bib35">Howie et al., 2009</xref>) was used to impute genotypes utilizing all populations from the 1000 Genomes Project reference panel (phase 3) (<xref ref-type="bibr" rid="bib1">1000 Genomes Project Consortium et al., 2015</xref>). Genotypes were called for imputed SNPs with allelic R2 values greater than 0.9. Mapping between genomic coordinates was performed using liftOver (<xref ref-type="bibr" rid="bib43">Kuhn et al., 2013</xref>). VCF files were subset by genotypes for the donors of interest using VCFtools (<xref ref-type="bibr" rid="bib20">Danecek et al., 2011</xref>).</p><p>To identify donors across the in vitro dataset, snATAC- and snRNA-seq output BAM files from Cell Ranger ARC (10X Genomics, v.2.0.0; <xref ref-type="bibr" rid="bib28">Genomics x, 2022a</xref>) were concatenated, sorted, and indexed using samtools (<xref ref-type="bibr" rid="bib21">Danecek et al., 2021</xref>). The concatenated BAM files were input with the genotype VCF file to demuxlet (<xref ref-type="bibr" rid="bib38">Kang et al., 2018</xref>) to identify best matched donors for each cell barcode, using options ‘–field GT’. Verification of accurate donor identification was confirmed by visualizing female sex-specific <italic>XIST</italic> for the known donor sexes (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>).</p></sec><sec id="s4-5"><title>snRNA-seq bioinformatics workflow</title><p>A target of 10,000 nuclei were loaded onto each lane. Libraries were sequenced on NovaSeq6000. Reads were aligned to the GRCh38 (hg38) reference genome and quantified using Cell Ranger ARC (10X Genomics, v.2.0.0; <xref ref-type="bibr" rid="bib28">Genomics x, 2022a</xref>). Datasets were subsequently preprocessed for RNA individually with Seurat version 4.3.0 (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>). Seurat objects were created from each dataset, and cells with &lt;500 counts were removed. This is a quality control step as it is thought that cells with low number of counts are poor data quality. Similarly, for each cell, the percentage of counts that come from mitochondrial genes was determined. Cells with &gt;20% mitochondrial gene percent expression (which are thought to be of low quality, possibly due to membrane rupture) were excluded. Demuxlet (<xref ref-type="bibr" rid="bib38">Kang et al., 2018</xref>) was next used to remove doublets. The filtered library was subset and merged by pro-EndMT perturbation. Data were normalized with NormalizeData, and cell cycle regression was performed by generating cell cycle phase scores for each cell using CellCycleScoring, followed by regression of these using ScaleData (<xref ref-type="bibr" rid="bib51">Luecken and Theis, 2019</xref>). Batch effects by treatment were corrected using FindIntegrationAnchors using 10,000 anchors, followed by IntegrateData.</p></sec><sec id="s4-6"><title>snATAC-seq bioinformatics workflow</title><p>A target of 10,000 nuclei were loaded onto each lane. Libraries were sequenced on an NovaSeq 6000 according to manufacturer’s specifications at the University of Chicago. Reads were aligned to the GRCh38 (hg38) reference genome and quantified using Cell Ranger ARC (10X Genomics, v.2.0.0; <xref ref-type="bibr" rid="bib28">Genomics x, 2022a</xref>). Datasets were subsequently preprocessed for ATAC individually with Seurat v4.3.0 (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>) and Signac v1.6.0 (<xref ref-type="bibr" rid="bib33">Heidecker et al., 2010</xref>) to remove low-quality nuclei (nucleosome signal &gt;2, transcription start site enrichment &lt;1, ATAC count &lt;500, and % mitochondrial genes &gt;20) (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>). Next, demuxlet (<xref ref-type="bibr" rid="bib38">Kang et al., 2018</xref>) was used to remove doublets. A common peak set was quantified across snATAC-seq libraries using FeatureMatrix, prior to merging each lane. A series of two iterative peak calling steps were performed. The first step consisted of calling peaks for every EndMT perturbation, and the second involved calling peaks for every cluster generated from weighted nearest-neighbor analysis (WNN) (see ‘Integration and weighted nearest-neighbor analyses’). Latent semantic indexing (LSI) was computed after each iterative peak calling step using Signac standard workflow (<xref ref-type="bibr" rid="bib77">Stuart et al., 2021</xref>). Batch effects by treatment were finally corrected using FindIntegrationAnchors using 10,000 anchors, followed by IntegrateData.</p></sec><sec id="s4-7"><title>Integration and weighted nearest-neighbor analyses</title><p>Following snRNA-seq and snATAC-seq quality control filtering, barcodes for each modality were matched, and both datasets were combined by adding the snATAC-seq assay and integrated LSI to the snRNA-seq assay. WNN (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>) was next calculated on the combined dataset, followed by joint UMAP (<sub>WNN</sub>UMAP) visualization using Signac (<xref ref-type="bibr" rid="bib77">Stuart et al., 2021</xref>) functions FindMultimodalNeighbors, RunUMAP, and FindClusters, respectively. WNN is an unsupervised framework to learn the relative utility of each data type in each cell, enabling an integrative analysis of multimodal datasets. This process involves learning cell-specific modality ‘weights’ and constructing a <sub>WNN</sub>UMAP that integrates the modalities. The subtypes discovered in the first round of WNN were utilized in an additional peak calling step for snATAC-seq, followed by LSI computation, re-integration, and a final round of WNN to achieve optimal peak predictions (see ‘Single-Nucleus ATAC sequencing bioinformatics workflow’) (<xref ref-type="bibr" rid="bib90">Yan et al., 2020</xref>).</p></sec><sec id="s4-8"><title>Differential expression and accessibility region analyses across EC subtypes and EndMT perturbation–subtype combinations</title><p>Differential expression between clusters was computed by constructing a logistic regression (LR) model predicting group membership based on the expression of a given gene in the set of cells being compared. The LR model included pro-EndMT perturbation as a latent variable and was compared to a null model using a likelihood ratio test. This was performed using Seurat FindMarkers, with ‘test.use=LR’ and ‘latent.vars’ set to perturbation. Differential expression between perturbation and control for each cluster was performed using pseudobulk method with DESeq2 (<xref ref-type="bibr" rid="bib50">Love et al., 2014</xref>). Raw RNA counts were extracted for each EndMT perturbation-subtype combination and counts, and metadata were aggregated to the sample level.</p><p>Differential accessibility between EC subtypes was performed using FindMarkers, with ‘test.use=LR’ and latent.vars set to both the number of reads in peaks and perturbation. Finally, differential accessibility between perturbation and control for each cluster was performed using FindMarkers, with ‘test.use=LR’ and latent.vars set to the number of reads in peaks.</p><p>Bonferroni-adjusted p-values were used to determine significance at adjusted p-value&lt;0.05 for differential expression, and p-value&lt;0.005 for differential accessibility (<xref ref-type="bibr" rid="bib5">Benjamini and Hochberg, 1995</xref>).</p></sec><sec id="s4-9"><title>Pathway enrichment analysis</title><p>Pathway enrichment analysis (PEA) was performed using Metascape (<xref ref-type="bibr" rid="bib98">Zhou et al., 2019</xref>). Top DEGs for each EC subtype or subtype–perturbation were sorted based on ascending p-value. Genes listed for each pathway were pulled from the Metacape results file, ‘_FINAL_GO.csv’. For heatmaps produced by metascape, top 20 or 100 pathways were pulled from Metascape.png files, ‘HeatmapSelectedGO.png’, ‘HeatmapSelectedGOParent.png’, or ‘HeatmapSelectedGOTop100.png’.</p></sec><sec id="s4-10"><title>Motif enrichment analysis</title><p>A hypergeometric test was used to test for overrepresentation of each DNA motif in the set of differentially accessible peaks compared to a background set of peaks. We tested motifs present in the Jaspar database (2020 release) (<xref ref-type="bibr" rid="bib27">Fornes et al., 2020</xref>) by first identifying which peaks contained each motif using motifmatchr R package (<ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/motifmatchr">https://bioconductor.org/packages/motifmatchr</ext-link>). We computed the GC content (percentage of G and C nucleotides) for each differentially accessible peak and sampled a background set of 40,000 peaks matched for GC content (<xref ref-type="bibr" rid="bib77">Stuart et al., 2021</xref>). Per-cell motif activity scores were computed by running chromVAR (<xref ref-type="bibr" rid="bib72">Schep et al., 2017</xref>), and visualized using Seurat (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>) function FeaturePlot.</p></sec><sec id="s4-11"><title>Human atherosclerosis scRNA-seq public data download, mapping, and integration across samples</title><p>Count matrices of 17 samples taken from four different published scRNA-seq datasets were downloaded from the NCBI Gene Expression Omnibus (accessions listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1k</xref>), processed using Cell Ranger (10X Genomics Cell Ranger 6.0.0; <xref ref-type="bibr" rid="bib97">Zheng et al., 2017</xref>) with reference GRCh38 (version refdata-gex-GRCh38-2020-A, 10X Genomics), and analyzed using Seurat version 4.3.0 (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>). Seurat objects were created from each dataset, and cells with &lt;500 counts and &gt;20% mitochondrial gene percent expression were excluded. Additionally, doublets were removed using DoubletFinder (<xref ref-type="bibr" rid="bib54">McGinnis et al., 2019</xref>), which predicts doublets according to each real cell’s proximity in gene expression space to artificial doublets created by averaging the transcriptional profile of randomly chosen cell pairs. Next, normalization and variance stabilization, followed by PC analysis for 30 PCs, were performed in Seurat (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>) using default parameters. Batch effects across the 17 samples were corrected using Seurat functions (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>) FindIntegrationAnchors using 10,000 anchors, followed by IntegrateData. During the integration step, cell cycle regression was performed by assigning cell cycle scores with Seurat (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>) function CellCycleScoring. The ex vivo dataset was first visualized, and canonical markers were identified for annotating cell types using FindAllMarkers.</p></sec><sec id="s4-12"><title>Module scoring</title><p>FindAllMarkers was used to identify the top DEGs between each ex vivo cell subtype. Cells from the in vitro dataset were assigned an ex vivo cell subtype module score using Seurat (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>) function AddModuleScore. The difference in module score between each in vitro EC subtype was established using Wilcoxon rank sum test with continuity correction and a two-sided alternative hypothesis.</p></sec><sec id="s4-13"><title>Comparison of ex vivo snRNA-seq data to in vitro snRNA-seq data</title><p>Meta-analyzed ex vivo human scRNA-seq data and in vitro snRNA-seq data were compared. Gene expression values for each ex vivo cell subtype and in vitro EC subtype–perturbation were produced using the AverageExpression function in Seurat (<xref ref-type="bibr" rid="bib32">Hao et al., 2021</xref>) (which exponentiates log data, therefore output is depth normalized in non-log space). <xref ref-type="fig" rid="fig6">Figure 6A</xref> was generated using hclust function in R (<xref ref-type="bibr" rid="bib58">Murtagh and Legendre, 2014</xref>). Spearman correlation was used as the distance metric. Sample clustering was performed using all significant genes (adjusted p-value &lt;0.05) induced and attenuated across all in vitro EC subtypes for each pro-EndMT perturbation versus its respective control. <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4A</xref> was made using average expression data for marker genes for each ex vivo cell subtype. Hierarchical clustering across ex vivo cell subtypes was performed using hclust function in R (<xref ref-type="bibr" rid="bib58">Murtagh and Legendre, 2014</xref>) using average expression as the distance metric for a given gene.</p></sec><sec id="s4-14"><title>GWAS SNP enrichment analysis</title><p>The SNPs associated with CAD were extracted from the most recent available meta-analysis (<xref ref-type="bibr" rid="bib79">Tcheandjieu et al., 2022</xref>). We utilized a matched background of SNPs pulled from 1000 Genomes Project reference panel (phase 3) (<xref ref-type="bibr" rid="bib1">1000 Genomes Project Consortium et al., 2015</xref>), which were filtered using PLINK (<xref ref-type="bibr" rid="bib65">Purcell et al., 2007</xref>) v1.90b5.3 with the following settings: ‘--maf 0.01’, ‘--geno 0.05’. Mapping between genomic coordinates was performed using liftOver (<xref ref-type="bibr" rid="bib43">Kuhn et al., 2013</xref>). To evaluate for enrichment in CAD-associated SNPs for each EC subtype and perturbation-subtype peak set, traseR package in R (traseR) (<xref ref-type="bibr" rid="bib15">Chen and Qin, 2016</xref>) was used with the following: ‘test.method’ = ‘fisher’, ‘alternative’ = ‘greater’.</p></sec><sec id="s4-15"><title>Peak-to-gene linkage</title><p>We estimated a linkage score for each peak-gene pair using the LinksPeaks function in Signac (<xref ref-type="bibr" rid="bib77">Stuart et al., 2021</xref>). For each gene, we computed the Pearson correlation coefficient <italic>r</italic> between the gene expression and the accessibility of each peak within 500 kb of the gene TSS. For each peak, we then computed a background set of expected correlation coefficients given properties of the peak by randomly sampling 200 peaks located on a different chromosome to the gene, matched for GC content, accessibility, and sequence length (MatchRegionStats function in Signac). We then computed the Pearson correlation between the expression of the gene and the set of background peaks. A z score was computed for each peak as <italic>z</italic> = (<italic>r − μ</italic>)/<italic>σ</italic>, where <italic>μ</italic> is the background mean correlation coefficient and <italic>σ</italic> is the SD of the background correlation coefficients for the peak. We computed a p-value for each peak using a one-sided z-test and retained peak-gene links with a p-value&lt;0.05 and a Pearson correlation coefficient. The results were restricted to peak regions that overlapped with significant CAD-associated SNPs (see ‘GWAS SNP enrichment analysis’).</p></sec><sec id="s4-16"><title>Data visualization</title><p>Data visualizations were performed using Seurat functions DimPlot, DotPlot, FeaturePlot, and VlnPlot. Other data visualizations were performed using ggplot2 (for stacked bar graphs) (<xref ref-type="bibr" rid="bib85">Villanueva and Chen, 2019</xref>), UpSetR (for UpSet plots) (<xref ref-type="bibr" rid="bib18">Conway et al., 2001</xref>), pheatmap (for DEG and DAR analysis heatmaps), and heatmap.2 (for Spearman’s rank correlation coefficient heatmap and <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4A</xref>; <xref ref-type="bibr" rid="bib86">Warnes et al., 2016</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Funding acquisition, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Methodology</p></fn><fn fn-type="con" id="con3"><p>Formal analysis</p></fn><fn fn-type="con" id="con4"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources</p></fn><fn fn-type="con" id="con7"><p>Resources</p></fn><fn fn-type="con" id="con8"><p>Supervision, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Formal analysis, Supervision, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><p>(a) The numbers of total reads and reads per nucleus in snRNA-seq and snATAC-seq data: total reads and reads per nucleus in snRNA-seq and snATAC-seq data are shown. (b) Cells and transcripts detected per nucleus for each snRNA-seq library after filtering during quality control. (c) Proportion of cells belonging to each donor for each EC cluster. (d) Markers for each cluster: discovered using Seurat’s FindAllMarkers function with latent.vars set to ‘Treatment’. Each gene is tested for differential expression between cells of each cluster and the cells outside of that cluster. p_val corresponds to the p-value of the Wilcoxon rank sum test, avg_log2FC is the log2-fold change in expression of the marker for the average cell in the cluster. Subtype is the designated subtype chosen for each cluster, cluster is the cluster of cells for which the marker was discovered, gene is the markers, pct.1 is the percentage of cells expressing the marker within the tested cluster, pct.2 is the percentage of cells expressing the marker outside the cluster, and p_val_adj is the Bonferroni adjusted p-value (based on the number of genes tested). (e) Top biological pathways from Metascape pathway enrichment analysis (and corresponding p-values) taken from top 100 significant genes for each cluster from FindAllMarkers. (f) Cells and peaks detected per nucleus for each snATAC-seq library after filtering during quality control. (g) List of chemical and genetic perturbations that each primary cell donor underwent: TGFB2=7-day TGFB2 (10 ng/ml); IL1B=7-day IL1B (10 ng/ml); IL1B6h=6 hr IL1B (1 ng/ml); siERG = siRNA-mediated knock-down of ERG (siERG), achieved with serial transfections on days 0 and 4. Ancestries were determined according to 1000 Genomes Project superpopulations. (h) Differential accessible regions (p&lt;0.005) across EC subtypes. (i) Differentially expressed genes (DEGs) with TGFB2, IL1B, or siERG induction across EC subtypes: briefly, pseudobulk DEG analysis is performed to find genes that are significantly differentially expressed between perturbations and respective controls for pan ECs (EC1-4) and each EC subtype. DEGs with adjusted p-value&lt;0.05 are considered significant and listed below. (j) Differentially accessible regions affected by TGFB2, IL1B, or siERG across EC subtypes: briefly, significant DARs were found using FindMarkers using logistic regression with ‘nCount_ATAC’ set as a latent variable. DARs with p&lt;0.005 were considered significant and listed below. (k) Description of public data used in this study. (l) Markers for each cluster: discovered using Seurat’s FindAllMarkers function; briefly, each gene is tested for differential expression between cells of each cluster and the cells outside of that cluster. p_val corresponds to the p-value of the Wilcoxon rank sum test, avg_log2FC is the log2-fold change in expression of the marker for the average cell in the cell type, cell type is the collapsed cluster of cells for which the marker was discovered, gene is the markers, pct.1 is the percentage of cells expressing the marker within the tested cluster, pct.2 is the percentage of cells expressing the marker outside the cluster, and p_val_adj is the Bonferroni adjusted p-value (based on the number of genes tested). (m) Effect of EndMT perturbation on in vitro EC subtypes according to ex vivo cell type module scores: Adjusted p-values&lt;0.05 are generated using Wilcoxon rank sum test with continuity correction setting alternative hypothesis to ‘two.sided’. Colored arrows represent significantly (adjusted p-value&lt;0.05) upregulated (green) and downregulated (red) module scores for each EC sub-phenotype and perturbation combination. (n) Results table for effect of EndMT perturbation on in vitro EC subtypes according to ex vivo cell type module scores: Adjusted p-values&lt;0.05 are generated using Wilcoxon rank sum test with continuity correction setting alternative hypothesis to ‘two.sided’. (o) SNP enrichment analysis results across clusters and perturbation-cluster combinations: briefly, SNP enrichment analysis was used with traseR with 'test.method' set to ‘fisher’ and 'alternative' set to ‘greater’. (p) Significantly enriched SNPs (adjusted p-value&lt;0.05) across clusters and perturbation-cluster combinations: briefly, SNP enrichment analysis was used with traseR with 'test.method' set to ‘fisher’ and 'alternative' set to ‘greater’. (q) Significant links between genes and EC4-specific peaks which overlap with CAD-associated SNPs (p-value&lt;0.05): Briefly, peak-to-gene linkage was performed using Signac ‘LinkPeaks’ function on a dataset consisting of EC4-specific peaks and genes. Results were filtered based on peak regions which overlap with significant (p&lt;5e-8) CAD associated SNPs. (r) siRNAs and qPCR primers used in this study. siERG #1, #2, #4, and #5 were pooled together. Non-targeting siRNA (siSCR) #3 and #4 were pooled together.</p></caption><media xlink:href="elife-91729-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-91729-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE228428. This project utilized data deposited previously in GEO accessions GSE155512, GSE159677, and GSE131778. The code used for analysis can be found in GitHub at <ext-link ext-link-type="uri" xlink:href="https://github.com/cromanoski/Adelus_2024_Elife/">https://github.com/cromanoski/Adelus_2024_Elife/</ext-link> (copy archived at <xref ref-type="bibr" rid="bib70">Romanoski, 2024</xref>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Adelus</surname><given-names>ML</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Tran</surname><given-names>BT</given-names></name><name><surname>Conklin</surname><given-names>AC</given-names></name><name><surname>Golebiewski</surname><given-names>AK</given-names></name><name><surname>Stolze</surname><given-names>LK</given-names></name><name><surname>Whalen</surname><given-names>MB</given-names></name><name><surname>Cusanovich</surname><given-names>DA</given-names></name><name><surname>Romanoski</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Multiomic profiling of in vitro models of endothelial-to-mesenchymal transition reveals endothelial cell subtype is a major determinant of fidelity to observed states in atherosclerosis</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228428">GSE228428</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Huize</surname><given-names>P</given-names></name><name><surname>Chenyi</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE155512">GSE155512</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Alsaigh</surname><given-names>T</given-names></name><name><surname>Evans</surname><given-names>D</given-names></name><name><surname>Frankel</surname><given-names>D</given-names></name><name><surname>Torkamani</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Decoding the transcriptome of calcified atherosclerotic plaque at single-cell resolution</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE159677">GSE159677</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Wirka</surname><given-names>RC</given-names></name><name><surname>Wagh</surname><given-names>D</given-names></name><name><surname>Paik</surname><given-names>DT</given-names></name><name><surname>Pjanic</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>CL</given-names></name><name><surname>Kundu</surname><given-names>R</given-names></name><name><surname>Nagao</surname><given-names>M</given-names></name><name><surname>Coller</surname><given-names>J</given-names></name><name><surname>Koyano</surname><given-names>T</given-names></name><name><surname>Fong</surname><given-names>R</given-names></name><name><surname>Woo</surname><given-names>YJ</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Montgomery</surname><given-names>SB</given-names></name><name><surname>Zhu</surname><given-names>K</given-names></name><name><surname>Chang</surname><given-names>R</given-names></name><name><surname>Alamprese</surname><given-names>M</given-names></name><name><surname>Tallquist</surname><given-names>MD</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Quertermous</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131778">GSE131778</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This study was funded by grants from the National Institutes of Health through R01HL147187 (CER), R35GM137896 (DAC), F30HL162469 (MLA), T32HL7249-45 (MLA), and the Geneen Charitable Trust Awards Program for Coronary Heart Disease Research (CER).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>1000 Genomes Project Consortium</collab><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Brooks</surname><given-names>LD</given-names></name><name><surname>Durbin</surname><given-names>RM</given-names></name><name><surname>Garrison</surname><given-names>EP</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Marchini</surname><given-names>JL</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><name><surname>McVean</surname><given-names>GA</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A global reference for human genetic variation</article-title><source>Nature</source><volume>526</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature15393</pub-id><pub-id pub-id-type="pmid">26432245</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsaigh</surname><given-names>T</given-names></name><name><surname>Evans</surname><given-names>D</given-names></name><name><surname>Frankel</surname><given-names>D</given-names></name><name><surname>Torkamani</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Decoding the transcriptome of calcified atherosclerotic plaque at single-cell resolution</article-title><source>Communications Biology</source><volume>5</volume><elocation-id>1084</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-022-04056-7</pub-id><pub-id pub-id-type="pmid">36224302</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andueza</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>D-W</given-names></name><name><surname>Mumme</surname><given-names>HL</given-names></name><name><surname>Perez</surname><given-names>JI</given-names></name><name><surname>Villa-Roel</surname><given-names>N</given-names></name><name><surname>Jo</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Endothelial reprogramming by disturbed flow revealed by Single-Cell RNA and chromatin accessibility study</article-title><source>Cell Reports</source><volume>33</volume><elocation-id>108491</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108491</pub-id><pub-id pub-id-type="pmid">33326796</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aragam</surname><given-names>KG</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Wolford</surname><given-names>BN</given-names></name><name><surname>Atri</surname><given-names>DS</given-names></name><name><surname>Weeks</surname><given-names>EM</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Hindy</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Grace</surname><given-names>C</given-names></name><name><surname>Roselli</surname><given-names>C</given-names></name><name><surname>Marston</surname><given-names>NA</given-names></name><name><surname>Kamanu</surname><given-names>FK</given-names></name><name><surname>Surakka</surname><given-names>I</given-names></name><name><surname>Venegas</surname><given-names>LM</given-names></name><name><surname>Sherliker</surname><given-names>P</given-names></name><name><surname>Koyama</surname><given-names>S</given-names></name><name><surname>Ishigaki</surname><given-names>K</given-names></name><name><surname>Åsvold</surname><given-names>BO</given-names></name><name><surname>Brown</surname><given-names>MR</given-names></name><name><surname>Brumpton</surname><given-names>B</given-names></name><name><surname>de Vries</surname><given-names>PS</given-names></name><name><surname>Giannakopoulou</surname><given-names>O</given-names></name><name><surname>Giardoglou</surname><given-names>P</given-names></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Güldener</surname><given-names>U</given-names></name><name><surname>Haider</surname><given-names>SMI</given-names></name><name><surname>Helgadottir</surname><given-names>A</given-names></name><name><surname>Ibrahim</surname><given-names>M</given-names></name><name><surname>Kastrati</surname><given-names>A</given-names></name><name><surname>Kessler</surname><given-names>T</given-names></name><name><surname>Kyriakou</surname><given-names>T</given-names></name><name><surname>Konopka</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Mucha</surname><given-names>S</given-names></name><name><surname>Munz</surname><given-names>M</given-names></name><name><surname>Murgia</surname><given-names>F</given-names></name><name><surname>Nielsen</surname><given-names>JB</given-names></name><name><surname>Nöthen</surname><given-names>MM</given-names></name><name><surname>Pang</surname><given-names>S</given-names></name><name><surname>Reinberger</surname><given-names>T</given-names></name><name><surname>Schnitzler</surname><given-names>G</given-names></name><name><surname>Smedley</surname><given-names>D</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>von Scheidt</surname><given-names>M</given-names></name><name><surname>Ulirsch</surname><given-names>JC</given-names></name><collab>Biobank Japan</collab><collab>EPIC-CVD</collab><name><surname>Arnar</surname><given-names>DO</given-names></name><name><surname>Burtt</surname><given-names>NP</given-names></name><name><surname>Costanzo</surname><given-names>MC</given-names></name><name><surname>Flannick</surname><given-names>J</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Jang</surname><given-names>D-K</given-names></name><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Khera</surname><given-names>AV</given-names></name><name><surname>Komuro</surname><given-names>I</given-names></name><name><surname>Kullo</surname><given-names>IJ</given-names></name><name><surname>Lotta</surname><given-names>LA</given-names></name><name><surname>Nelson</surname><given-names>CP</given-names></name><name><surname>Roberts</surname><given-names>R</given-names></name><name><surname>Thorgeirsson</surname><given-names>G</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Webb</surname><given-names>TR</given-names></name><name><surname>Baras</surname><given-names>A</given-names></name><name><surname>Björkegren</surname><given-names>JLM</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Dedoussis</surname><given-names>G</given-names></name><name><surname>Holm</surname><given-names>H</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Morrison</surname><given-names>AC</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Rallidis</surname><given-names>LS</given-names></name><name><surname>Ruusalepp</surname><given-names>A</given-names></name><name><surname>Sabatine</surname><given-names>MS</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Zalloua</surname><given-names>P</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Farrall</surname><given-names>M</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Ruff</surname><given-names>CT</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name><name><surname>Hopewell</surname><given-names>JC</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Gupta</surname><given-names>RM</given-names></name><name><surname>Erdmann</surname><given-names>J</given-names></name><name><surname>Samani</surname><given-names>NJ</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name><name><surname>Watkins</surname><given-names>H</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Butterworth</surname><given-names>AS</given-names></name><collab>CARDIoGRAMplusC4D Consortium</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants</article-title><source>Nature Genetics</source><volume>54</volume><fpage>1803</fpage><lpage>1815</lpage><pub-id pub-id-type="doi">10.1038/s41588-022-01233-6</pub-id><pub-id pub-id-type="pmid">36474045</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title><source>Journal of the Royal Statistical Society</source><volume>57</volume><fpage>289</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1111/j.2517-6161.1995.tb02031.x</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birdsey</surname><given-names>GM</given-names></name><name><surname>Shah</surname><given-names>AV</given-names></name><name><surname>Dufton</surname><given-names>N</given-names></name><name><surname>Reynolds</surname><given-names>LE</given-names></name><name><surname>Osuna Almagro</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Aspalter</surname><given-names>IM</given-names></name><name><surname>Khan</surname><given-names>ST</given-names></name><name><surname>Mason</surname><given-names>JC</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Hodivala-Dilke</surname><given-names>K</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Adams</surname><given-names>RH</given-names></name><name><surname>Randi</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The endothelial transcription factor ERG promotes vascular stability and growth through Wnt/β-catenin signaling</article-title><source>Developmental Cell</source><volume>32</volume><fpage>82</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.11.016</pub-id><pub-id pub-id-type="pmid">25584796</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bondareva</surname><given-names>O</given-names></name><name><surname>Rodríguez-Aguilera</surname><given-names>JR</given-names></name><name><surname>Oliveira</surname><given-names>F</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name><name><surname>Rose</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Geier</surname><given-names>F</given-names></name><name><surname>Schuster</surname><given-names>J</given-names></name><name><surname>Boeckel</surname><given-names>J-N</given-names></name><name><surname>Buescher</surname><given-names>JM</given-names></name><name><surname>Kohli</surname><given-names>S</given-names></name><name><surname>Klöting</surname><given-names>N</given-names></name><name><surname>Isermann</surname><given-names>B</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><name><surname>Sheikh</surname><given-names>BN</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Single-cell profiling of vascular endothelial cells reveals progressive organ-specific vulnerabilities during obesity</article-title><source>Nature Metabolism</source><volume>4</volume><fpage>1591</fpage><lpage>1610</lpage><pub-id pub-id-type="doi">10.1038/s42255-022-00674-x</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JC</given-names></name><name><surname>Gerhardt</surname><given-names>TE</given-names></name><name><surname>Kwon</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Risk factors for coronary artery disease</data-title><source>StatPearls</source></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bujak</surname><given-names>M</given-names></name><name><surname>Dobaczewski</surname><given-names>M</given-names></name><name><surname>Chatila</surname><given-names>K</given-names></name><name><surname>Mendoza</surname><given-names>LH</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Reddy</surname><given-names>A</given-names></name><name><surname>Frangogiannis</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling</article-title><source>The American Journal of Pathology</source><volume>173</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2008.070974</pub-id><pub-id pub-id-type="pmid">18535174</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bujak</surname><given-names>M</given-names></name><name><surname>Frangogiannis</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The role of IL-1 in the pathogenesis of heart disease</article-title><source>Archivum Immunologiae et Therapiae Experimentalis</source><volume>57</volume><fpage>165</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1007/s00005-009-0024-y</pub-id><pub-id pub-id-type="pmid">19479203</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Cusanovich</surname><given-names>DA</given-names></name><name><surname>Ramani</surname><given-names>V</given-names></name><name><surname>Aghamirzaie</surname><given-names>D</given-names></name><name><surname>Pliner</surname><given-names>HA</given-names></name><name><surname>Hill</surname><given-names>AJ</given-names></name><name><surname>Daza</surname><given-names>RM</given-names></name><name><surname>McFaline-Figueroa</surname><given-names>JL</given-names></name><name><surname>Packer</surname><given-names>JS</given-names></name><name><surname>Christiansen</surname><given-names>L</given-names></name><name><surname>Steemers</surname><given-names>FJ</given-names></name><name><surname>Adey</surname><given-names>AC</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Joint profiling of chromatin accessibility and gene expression in thousands of single cells</article-title><source>Science</source><volume>361</volume><fpage>1380</fpage><lpage>1385</lpage><pub-id pub-id-type="doi">10.1126/science.aau0730</pub-id><pub-id pub-id-type="pmid">30166440</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhuri</surname><given-names>V</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Karasek</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis</article-title><source>Journal of Cutaneous Pathology</source><volume>34</volume><fpage>146</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0560.2006.00584.x</pub-id><pub-id pub-id-type="pmid">17244026</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P-Y</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Barnes</surname><given-names>C</given-names></name><name><surname>Charisse</surname><given-names>K</given-names></name><name><surname>Yi</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Ali</surname><given-names>R</given-names></name><name><surname>Medina</surname><given-names>PP</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Slack</surname><given-names>FJ</given-names></name><name><surname>Anderson</surname><given-names>DG</given-names></name><name><surname>Kotelianski</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Tellides</surname><given-names>G</given-names></name><name><surname>Simons</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression</article-title><source>Cell Reports</source><volume>2</volume><fpage>1684</fpage><lpage>1696</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2012.10.021</pub-id><pub-id pub-id-type="pmid">23200853</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P-Y</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Baeyens</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Afolabi</surname><given-names>T</given-names></name><name><surname>Budatha</surname><given-names>M</given-names></name><name><surname>Tellides</surname><given-names>G</given-names></name><name><surname>Schwartz</surname><given-names>MA</given-names></name><name><surname>Simons</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Endothelial-to-mesenchymal transition drives atherosclerosis progression</article-title><source>The Journal of Clinical Investigation</source><volume>125</volume><fpage>4514</fpage><lpage>4528</lpage><pub-id pub-id-type="doi">10.1172/JCI82719</pub-id><pub-id pub-id-type="pmid">26517696</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Qin</surname><given-names>ZS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals</article-title><source>Bioinformatics</source><volume>32</volume><fpage>1214</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv741</pub-id><pub-id pub-id-type="pmid">26685307</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Lan</surname><given-names>T</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell RNA sequencing reveals cell type- and artery type-specific vascular remodelling in male spontaneously hypertensive rats</article-title><source>Cardiovascular Research</source><volume>117</volume><fpage>1202</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvaa164</pub-id><pub-id pub-id-type="pmid">32589721</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname><given-names>RR</given-names></name><name><surname>D’Addabbo</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Veizades</surname><given-names>S</given-names></name><name><surname>Sasagawa</surname><given-names>K</given-names></name><name><surname>Louis</surname><given-names>DM</given-names></name><name><surname>Cheng</surname><given-names>P</given-names></name><name><surname>Sokol</surname><given-names>J</given-names></name><name><surname>Jensen</surname><given-names>A</given-names></name><name><surname>Tso</surname><given-names>A</given-names></name><name><surname>Shankar</surname><given-names>V</given-names></name><name><surname>Wendel</surname><given-names>BS</given-names></name><name><surname>Bakerman</surname><given-names>I</given-names></name><name><surname>Liang</surname><given-names>G</given-names></name><name><surname>Koyano</surname><given-names>T</given-names></name><name><surname>Fong</surname><given-names>R</given-names></name><name><surname>Nau</surname><given-names>AN</given-names></name><name><surname>Ahmad</surname><given-names>H</given-names></name><name><surname>Gopakumar</surname><given-names>J</given-names></name><name><surname>Wirka</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>AS</given-names></name><name><surname>Boyd</surname><given-names>J</given-names></name><name><surname>Woo</surname><given-names>YJ</given-names></name><name><surname>Quertermous</surname><given-names>T</given-names></name><name><surname>Gulati</surname><given-names>GS</given-names></name><name><surname>Jaiswal</surname><given-names>S</given-names></name><name><surname>Chien</surname><given-names>Y-H</given-names></name><name><surname>Chan</surname><given-names>CKF</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name><name><surname>Nguyen</surname><given-names>PK</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Human coronary plaque T cells are clonal and cross-react to virus and self</article-title><source>Circulation Research</source><volume>130</volume><fpage>1510</fpage><lpage>1530</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.121.320090</pub-id><pub-id pub-id-type="pmid">35430876</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname><given-names>EM</given-names></name><name><surname>Collen</surname><given-names>D</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Molecular mechanisms of blood vessel growth</article-title><source>Cardiovascular Research</source><volume>49</volume><fpage>507</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1016/s0008-6363(00)00281-9</pub-id><pub-id pub-id-type="pmid">11166264</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahal</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Murray</surname><given-names>BT</given-names></name><name><surname>Mahler</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Endothelial to mesenchymal transformation is induced by altered extracellular matrix in aortic valve endothelial cells</article-title><source>Journal of Biomedical Materials Research. Part A</source><volume>105</volume><fpage>2729</fpage><lpage>2741</lpage><pub-id pub-id-type="doi">10.1002/jbm.a.36133</pub-id><pub-id pub-id-type="pmid">28589644</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Albers</surname><given-names>CA</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>DePristo</surname><given-names>MA</given-names></name><name><surname>Handsaker</surname><given-names>RE</given-names></name><name><surname>Lunter</surname><given-names>G</given-names></name><name><surname>Marth</surname><given-names>GT</given-names></name><name><surname>Sherry</surname><given-names>ST</given-names></name><name><surname>McVean</surname><given-names>G</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><collab>1000 Genomes Project Analysis Group</collab></person-group><year iso-8601-date="2011">2011</year><article-title>The variant call format and VCFtools</article-title><source>Bioinformatics</source><volume>27</volume><fpage>2156</fpage><lpage>2158</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr330</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Bonfield</surname><given-names>JK</given-names></name><name><surname>Liddle</surname><given-names>J</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Ohan</surname><given-names>V</given-names></name><name><surname>Pollard</surname><given-names>MO</given-names></name><name><surname>Whitwham</surname><given-names>A</given-names></name><name><surname>Keane</surname><given-names>T</given-names></name><name><surname>McCarthy</surname><given-names>SA</given-names></name><name><surname>Davies</surname><given-names>RM</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Twelve years of SAMtools and BCFtools</article-title><source>GigaScience</source><volume>10</volume><elocation-id>giab008</elocation-id><pub-id pub-id-type="doi">10.1093/gigascience/giab008</pub-id><pub-id pub-id-type="pmid">33590861</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>Q</given-names></name><name><surname>Zhai</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Shan</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>AGEs-RAGE axis causes endothelial-to-mesenchymal transition in early calcific aortic valve disease via TGF-β1 and BMPR2 signaling</article-title><source>Experimental Gerontology</source><volume>141</volume><elocation-id>111088</elocation-id><pub-id pub-id-type="doi">10.1016/j.exger.2020.111088</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drobni</surname><given-names>ZD</given-names></name><name><surname>Kolossvary</surname><given-names>M</given-names></name><name><surname>Karady</surname><given-names>J</given-names></name><name><surname>Jermendy</surname><given-names>AL</given-names></name><name><surname>Tarnoki</surname><given-names>AD</given-names></name><name><surname>Tarnoki</surname><given-names>DL</given-names></name><name><surname>Simon</surname><given-names>J</given-names></name><name><surname>Szilveszter</surname><given-names>B</given-names></name><name><surname>Littvay</surname><given-names>L</given-names></name><name><surname>Voros</surname><given-names>S</given-names></name><name><surname>Jermendy</surname><given-names>G</given-names></name><name><surname>Merkely</surname><given-names>B</given-names></name><name><surname>Maurovich-Horvat</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Heritability of coronary artery disease: insights from a classical twin study</article-title><source>Circulation. Cardiovascular Imaging</source><volume>15</volume><elocation-id>e013348</elocation-id><pub-id pub-id-type="doi">10.1161/CIRCIMAGING.121.013348</pub-id><pub-id pub-id-type="pmid">35290075</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekiz</surname><given-names>HA</given-names></name><name><surname>Conley</surname><given-names>CJ</given-names></name><name><surname>Stephens</surname><given-names>WZ</given-names></name><name><surname>O’Connell</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CIPR: a web-based R/shiny app and R package to annotate cell clusters in single cell RNA sequencing experiments</article-title><source>BMC Bioinformatics</source><volume>21</volume><elocation-id>191</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-020-3538-2</pub-id><pub-id pub-id-type="pmid">32414321</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evrard</surname><given-names>SM</given-names></name><name><surname>Lecce</surname><given-names>L</given-names></name><name><surname>Michelis</surname><given-names>KC</given-names></name><name><surname>Nomura-Kitabayashi</surname><given-names>A</given-names></name><name><surname>Pandey</surname><given-names>G</given-names></name><name><surname>Purushothaman</surname><given-names>K-R</given-names></name><name><surname>d’Escamard</surname><given-names>V</given-names></name><name><surname>Li</surname><given-names>JR</given-names></name><name><surname>Hadri</surname><given-names>L</given-names></name><name><surname>Fujitani</surname><given-names>K</given-names></name><name><surname>Moreno</surname><given-names>PR</given-names></name><name><surname>Benard</surname><given-names>L</given-names></name><name><surname>Rimmele</surname><given-names>P</given-names></name><name><surname>Cohain</surname><given-names>A</given-names></name><name><surname>Mecham</surname><given-names>B</given-names></name><name><surname>Randolph</surname><given-names>GJ</given-names></name><name><surname>Nabel</surname><given-names>EG</given-names></name><name><surname>Hajjar</surname><given-names>R</given-names></name><name><surname>Fuster</surname><given-names>V</given-names></name><name><surname>Boehm</surname><given-names>M</given-names></name><name><surname>Kovacic</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11853</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11853</pub-id><pub-id pub-id-type="pmid">27340017</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fish</surname><given-names>JE</given-names></name><name><surname>Cantu Gutierrez</surname><given-names>M</given-names></name><name><surname>Dang</surname><given-names>LT</given-names></name><name><surname>Khyzha</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Veitch</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>HS</given-names></name><name><surname>Khor</surname><given-names>M</given-names></name><name><surname>Antounians</surname><given-names>L</given-names></name><name><surname>Njock</surname><given-names>M-S</given-names></name><name><surname>Boudreau</surname><given-names>E</given-names></name><name><surname>Herman</surname><given-names>AM</given-names></name><name><surname>Rhyner</surname><given-names>AM</given-names></name><name><surname>Ruiz</surname><given-names>OE</given-names></name><name><surname>Eisenhoffer</surname><given-names>GT</given-names></name><name><surname>Medina-Rivera</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>MD</given-names></name><name><surname>Wythe</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network</article-title><source>Development</source><volume>144</volume><fpage>2428</fpage><lpage>2444</lpage><pub-id pub-id-type="doi">10.1242/dev.146050</pub-id><pub-id pub-id-type="pmid">28536097</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornes</surname><given-names>O</given-names></name><name><surname>Castro-Mondragon</surname><given-names>JA</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>van der Lee</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Richmond</surname><given-names>PA</given-names></name><name><surname>Modi</surname><given-names>BP</given-names></name><name><surname>Correard</surname><given-names>S</given-names></name><name><surname>Gheorghe</surname><given-names>M</given-names></name><name><surname>Baranašić</surname><given-names>D</given-names></name><name><surname>Santana-Garcia</surname><given-names>W</given-names></name><name><surname>Tan</surname><given-names>G</given-names></name><name><surname>Chèneby</surname><given-names>J</given-names></name><name><surname>Ballester</surname><given-names>B</given-names></name><name><surname>Parcy</surname><given-names>F</given-names></name><name><surname>Sandelin</surname><given-names>A</given-names></name><name><surname>Lenhard</surname><given-names>B</given-names></name><name><surname>Wasserman</surname><given-names>WW</given-names></name><name><surname>Mathelier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>JASPAR 2020: update of the open-access database of transcription factor binding profiles</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>D87</fpage><lpage>D92</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz1001</pub-id><pub-id pub-id-type="pmid">31701148</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="software"><person-group person-group-type="author"><collab>Genomics x</collab></person-group><year iso-8601-date="2022">2022a</year><data-title>Chromium next GEM single cell Multiome ATAC + gene expression</data-title><source>Revision Fed August</source></element-citation></ref><ref id="bib29"><element-citation publication-type="software"><person-group person-group-type="author"><collab>Genomics x</collab></person-group><year iso-8601-date="2022">2022b</year><data-title>Nuclei isolation for single cell Multiome ATAC + gene expression sequencing</data-title><source>Revision C Ed</source></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gole</surname><given-names>S</given-names></name><name><surname>Tkachenko</surname><given-names>S</given-names></name><name><surname>Masannat</surname><given-names>T</given-names></name><name><surname>Baylis</surname><given-names>RA</given-names></name><name><surname>Cherepanova</surname><given-names>OA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Endothelial-to-mesenchymal transition in atherosclerosis: friend or foe?</article-title><source>Cells</source><volume>11</volume><elocation-id>19</elocation-id><pub-id pub-id-type="doi">10.3390/cells11192946</pub-id><pub-id pub-id-type="pmid">36230908</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajra</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>AI</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Hyduk</surname><given-names>SJ</given-names></name><name><surname>Collins</surname><given-names>T</given-names></name><name><surname>Cybulsky</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The NF-κB signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation</article-title><source>PNAS</source><volume>97</volume><fpage>9052</fpage><lpage>9057</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.16.9052</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names><suffix>III</suffix></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidecker</surname><given-names>B</given-names></name><name><surname>Lamirault</surname><given-names>G</given-names></name><name><surname>Kasper</surname><given-names>EK</given-names></name><name><surname>Wittstein</surname><given-names>IS</given-names></name><name><surname>Champion</surname><given-names>HC</given-names></name><name><surname>Breton</surname><given-names>E</given-names></name><name><surname>Russell</surname><given-names>SD</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Kittleson</surname><given-names>MM</given-names></name><name><surname>Baughman</surname><given-names>KL</given-names></name><name><surname>Hare</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences</article-title><source>European Heart Journal</source><volume>31</volume><fpage>1188</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehp549</pub-id><pub-id pub-id-type="pmid">20031959</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>NT</given-names></name><name><surname>Whalen</surname><given-names>MB</given-names></name><name><surname>Stolze</surname><given-names>LK</given-names></name><name><surname>Hadeli</surname><given-names>NK</given-names></name><name><surname>Lam</surname><given-names>MT</given-names></name><name><surname>Springstead</surname><given-names>JR</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Romanoski</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcriptional networks specifying homeostatic and inflammatory programs of gene expression in human aortic endothelial cells</article-title><source>eLife</source><volume>6</volume><elocation-id>e22536</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.22536</pub-id><pub-id pub-id-type="pmid">28585919</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howie</surname><given-names>BN</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name><name><surname>Marchini</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A flexible and accurate genotype imputation method for the next generation of genome-wide association studies</article-title><source>PLOS Genetics</source><volume>5</volume><elocation-id>e1000529</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000529</pub-id><pub-id pub-id-type="pmid">19543373</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalluri</surname><given-names>AS</given-names></name><name><surname>Vellarikkal</surname><given-names>SK</given-names></name><name><surname>Edelman</surname><given-names>ER</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell analysis of the normal mouse aorta reveals functionally distinct endothelial cell populations</article-title><source>Circulation</source><volume>140</volume><fpage>147</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.038362</pub-id><pub-id pub-id-type="pmid">31146585</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalucka</surname><given-names>J</given-names></name><name><surname>de Rooij</surname><given-names>LPMH</given-names></name><name><surname>Goveia</surname><given-names>J</given-names></name><name><surname>Rohlenova</surname><given-names>K</given-names></name><name><surname>Dumas</surname><given-names>SJ</given-names></name><name><surname>Meta</surname><given-names>E</given-names></name><name><surname>Conchinha</surname><given-names>NV</given-names></name><name><surname>Taverna</surname><given-names>F</given-names></name><name><surname>Teuwen</surname><given-names>L-A</given-names></name><name><surname>Veys</surname><given-names>K</given-names></name><name><surname>García-Caballero</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Geldhof</surname><given-names>V</given-names></name><name><surname>Sokol</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Treps</surname><given-names>L</given-names></name><name><surname>Borri</surname><given-names>M</given-names></name><name><surname>de Zeeuw</surname><given-names>P</given-names></name><name><surname>Dubois</surname><given-names>C</given-names></name><name><surname>Karakach</surname><given-names>TK</given-names></name><name><surname>Falkenberg</surname><given-names>KD</given-names></name><name><surname>Parys</surname><given-names>M</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Vinckier</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Fenton</surname><given-names>RA</given-names></name><name><surname>Schoonjans</surname><given-names>L</given-names></name><name><surname>Dewerchin</surname><given-names>M</given-names></name><name><surname>Eelen</surname><given-names>G</given-names></name><name><surname>Thienpont</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Bolund</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptome atlas of murine endothelial cells</article-title><source>Cell</source><volume>180</volume><fpage>764</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.01.015</pub-id><pub-id pub-id-type="pmid">32059779</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Subramaniam</surname><given-names>M</given-names></name><name><surname>Targ</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Maliskova</surname><given-names>L</given-names></name><name><surname>McCarthy</surname><given-names>E</given-names></name><name><surname>Wan</surname><given-names>E</given-names></name><name><surname>Wong</surname><given-names>S</given-names></name><name><surname>Byrnes</surname><given-names>L</given-names></name><name><surname>Lanata</surname><given-names>CM</given-names></name><name><surname>Gate</surname><given-names>RE</given-names></name><name><surname>Mostafavi</surname><given-names>S</given-names></name><name><surname>Marson</surname><given-names>A</given-names></name><name><surname>Zaitlen</surname><given-names>N</given-names></name><name><surname>Criswell</surname><given-names>LA</given-names></name><name><surname>Ye</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Multiplexed droplet single-cell RNA-sequencing using natural genetic variation</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1038/nbt.4042</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>T</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Coronary artery disease genetics enlightened by genome-wide association studies</article-title><source>JACC. Basic to Translational Science</source><volume>6</volume><fpage>610</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1016/j.jacbts.2021.04.001</pub-id><pub-id pub-id-type="pmid">34368511</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Taverna</surname><given-names>F</given-names></name><name><surname>Rohlenova</surname><given-names>K</given-names></name><name><surname>Treps</surname><given-names>L</given-names></name><name><surname>Geldhof</surname><given-names>V</given-names></name><name><surname>de Rooij</surname><given-names>L</given-names></name><name><surname>Sokol</surname><given-names>L</given-names></name><name><surname>Pircher</surname><given-names>A</given-names></name><name><surname>Conradi</surname><given-names>L-C</given-names></name><name><surname>Kalucka</surname><given-names>J</given-names></name><name><surname>Schoonjans</surname><given-names>L</given-names></name><name><surname>Eelen</surname><given-names>G</given-names></name><name><surname>Dewerchin</surname><given-names>M</given-names></name><name><surname>Karakach</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Goveia</surname><given-names>J</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>EndoDB: a database of endothelial cell transcriptomics data</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D736</fpage><lpage>D744</lpage><pub-id pub-id-type="doi">10.1093/nar/gky997</pub-id><pub-id pub-id-type="pmid">30357379</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacic</surname><given-names>JC</given-names></name><name><surname>Dimmeler</surname><given-names>S</given-names></name><name><surname>Harvey</surname><given-names>RP</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name><name><surname>Aikawa</surname><given-names>E</given-names></name><name><surname>Krenning</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review</article-title><source>Journal of the American College of Cardiology</source><volume>73</volume><fpage>190</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2018.09.089</pub-id><pub-id pub-id-type="pmid">30654892</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krizbai</surname><given-names>IA</given-names></name><name><surname>Gasparics</surname><given-names>Á</given-names></name><name><surname>Nagyőszi</surname><given-names>P</given-names></name><name><surname>Fazakas</surname><given-names>C</given-names></name><name><surname>Molnár</surname><given-names>J</given-names></name><name><surname>Wilhelm</surname><given-names>I</given-names></name><name><surname>Bencs</surname><given-names>R</given-names></name><name><surname>Rosivall</surname><given-names>L</given-names></name><name><surname>Sebe</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0119655</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0119655</pub-id><pub-id pub-id-type="pmid">25742314</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>RM</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Kent</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The UCSC genome browser and associated tools</article-title><source>Briefings in Bioinformatics</source><volume>14</volume><fpage>144</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1093/bib/bbs038</pub-id><pub-id pub-id-type="pmid">22908213</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lathen</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chow</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Nigam</surname><given-names>V</given-names></name><name><surname>Ashraf</surname><given-names>YA</given-names></name><name><surname>Yuan</surname><given-names>JX</given-names></name><name><surname>Robbins</surname><given-names>IM</given-names></name><name><surname>Thistlethwaite</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease</article-title><source>Circulation</source><volume>130</volume><fpage>1179</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.007822</pub-id><pub-id pub-id-type="pmid">25062690</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Albig</surname><given-names>AR</given-names></name><name><surname>Regner</surname><given-names>M</given-names></name><name><surname>Schiemann</surname><given-names>BJ</given-names></name><name><surname>Schiemann</surname><given-names>WP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism</article-title><source>Carcinogenesis</source><volume>29</volume><fpage>2243</fpage><lpage>2251</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgn199</pub-id><pub-id pub-id-type="pmid">18713838</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levi</surname><given-names>M</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name><name><surname>Büller</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Bidirectional relation between inflammation and coagulation</article-title><source>Circulation</source><volume>109</volume><fpage>2698</fpage><lpage>2704</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000131660.51520.9A</pub-id><pub-id pub-id-type="pmid">15184294</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Solomonidis</surname><given-names>EG</given-names></name><name><surname>Meloni</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>RS</given-names></name><name><surname>Duffin</surname><given-names>R</given-names></name><name><surname>Dobie</surname><given-names>R</given-names></name><name><surname>Magalhaes</surname><given-names>MS</given-names></name><name><surname>Henderson</surname><given-names>BEP</given-names></name><name><surname>Louwe</surname><given-names>PA</given-names></name><name><surname>D’Amico</surname><given-names>G</given-names></name><name><surname>Hodivala-Dilke</surname><given-names>KM</given-names></name><name><surname>Shah</surname><given-names>AM</given-names></name><name><surname>Mills</surname><given-names>NL</given-names></name><name><surname>Simons</surname><given-names>BD</given-names></name><name><surname>Gray</surname><given-names>GA</given-names></name><name><surname>Henderson</surname><given-names>NC</given-names></name><name><surname>Baker</surname><given-names>AH</given-names></name><name><surname>Brittan</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction</article-title><source>European Heart Journal</source><volume>40</volume><fpage>2507</fpage><lpage>2520</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehz305</pub-id><pub-id pub-id-type="pmid">31162546</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Zou</surname><given-names>X-Z</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Ge</surname><given-names>X-Y</given-names></name><name><surname>Yao</surname><given-names>M-Z</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>C-P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling</article-title><source>Life Sciences</source><volume>227</volume><fpage>64</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2019.04.038</pub-id><pub-id pub-id-type="pmid">31004656</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Ruter</surname><given-names>DL</given-names></name><name><surname>Quigley</surname><given-names>K</given-names></name><name><surname>Tanke</surname><given-names>NT</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Bautch</surname><given-names>VL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell RNA sequencing reveals endothelial cell transcriptome heterogeneity under homeostatic laminar flow</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>41</volume><fpage>2575</fpage><lpage>2584</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.121.316797</pub-id><pub-id pub-id-type="pmid">34433297</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luecken</surname><given-names>MD</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Current best practices in single-cell RNA-seq analysis: a tutorial</article-title><source>Molecular Systems Biology</source><volume>15</volume><elocation-id>e8746</elocation-id><pub-id pub-id-type="doi">10.15252/msb.20188746</pub-id><pub-id pub-id-type="pmid">31217225</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maleszewska</surname><given-names>M</given-names></name><name><surname>Moonen</surname><given-names>J</given-names></name><name><surname>Huijkman</surname><given-names>N</given-names></name><name><surname>van de Sluis</surname><given-names>B</given-names></name><name><surname>Krenning</surname><given-names>G</given-names></name><name><surname>Harmsen</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner</article-title><source>Immunobiology</source><volume>218</volume><fpage>443</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2012.05.026</pub-id><pub-id pub-id-type="pmid">22739237</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marenberg</surname><given-names>ME</given-names></name><name><surname>Risch</surname><given-names>N</given-names></name><name><surname>Berkman</surname><given-names>LF</given-names></name><name><surname>Floderus</surname><given-names>B</given-names></name><name><surname>de Faire</surname><given-names>U</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Genetic susceptibility to death from coronary heart disease in a study of twins</article-title><source>The New England Journal of Medicine</source><volume>330</volume><fpage>1041</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1056/NEJM199404143301503</pub-id><pub-id pub-id-type="pmid">8127331</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGinnis</surname><given-names>CS</given-names></name><name><surname>Murrow</surname><given-names>LM</given-names></name><name><surname>Gartner</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors</article-title><source>Cell Systems</source><volume>8</volume><fpage>329</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2019.03.003</pub-id><pub-id pub-id-type="pmid">30954475</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPherson</surname><given-names>R</given-names></name><name><surname>Tybjaerg-Hansen</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetics of coronary artery disease</article-title><source>Circulation Research</source><volume>118</volume><fpage>564</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.306566</pub-id><pub-id pub-id-type="pmid">26892958</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medici</surname><given-names>D</given-names></name><name><surname>Potenta</surname><given-names>S</given-names></name><name><surname>Kalluri</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling</article-title><source>The Biochemical Journal</source><volume>437</volume><fpage>515</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1042/BJ20101500</pub-id><pub-id pub-id-type="pmid">21585337</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moonen</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>ES</given-names></name><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Maleszewska</surname><given-names>M</given-names></name><name><surname>Koerts</surname><given-names>JA</given-names></name><name><surname>Brouwer</surname><given-names>LA</given-names></name><name><surname>van Kooten</surname><given-names>TG</given-names></name><name><surname>van Luyn</surname><given-names>MJA</given-names></name><name><surname>Zeebregts</surname><given-names>CJ</given-names></name><name><surname>Krenning</surname><given-names>G</given-names></name><name><surname>Harmsen</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress</article-title><source>Cardiovascular Research</source><volume>108</volume><fpage>377</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvv175</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murtagh</surname><given-names>F</given-names></name><name><surname>Legendre</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ward’s hierarchical agglomerative clustering method: which algorithms implement ward’s criterion?</article-title><source>Journal of Classification</source><volume>31</volume><fpage>274</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1007/s00357-014-9161-z</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>N</given-names></name><name><surname>Ohguchi</surname><given-names>H</given-names></name><name><surname>Nakaki</surname><given-names>R</given-names></name><name><surname>Matsumura</surname><given-names>Y</given-names></name><name><surname>Kanki</surname><given-names>Y</given-names></name><name><surname>Sakai</surname><given-names>J</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name><name><surname>Minami</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Downregulation of ERG and FLI1 expression in endothelial cells triggers endothelial-to-mesenchymal transition</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007826</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007826</pub-id><pub-id pub-id-type="pmid">30500808</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navab</surname><given-names>M</given-names></name><name><surname>Hough</surname><given-names>GP</given-names></name><name><surname>Stevenson</surname><given-names>LW</given-names></name><name><surname>Drinkwater</surname><given-names>DC</given-names></name><name><surname>Laks</surname><given-names>H</given-names></name><name><surname>Fogelman</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells</article-title><source>The Journal of Clinical Investigation</source><volume>82</volume><fpage>1853</fpage><lpage>1863</lpage><pub-id pub-id-type="doi">10.1172/JCI113802</pub-id><pub-id pub-id-type="pmid">3198759</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>C</given-names></name><name><surname>Buszczak</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The homeostatic regulation of ribosome biogenesis</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>136</volume><fpage>13</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2022.03.043</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Örd</surname><given-names>T</given-names></name><name><surname>Õunap</surname><given-names>K</given-names></name><name><surname>Stolze</surname><given-names>LK</given-names></name><name><surname>Aherrahrou</surname><given-names>R</given-names></name><name><surname>Nurminen</surname><given-names>V</given-names></name><name><surname>Toropainen</surname><given-names>A</given-names></name><name><surname>Selvarajan</surname><given-names>I</given-names></name><name><surname>Lönnberg</surname><given-names>T</given-names></name><name><surname>Aavik</surname><given-names>E</given-names></name><name><surname>Ylä-Herttuala</surname><given-names>S</given-names></name><name><surname>Civelek</surname><given-names>M</given-names></name><name><surname>Romanoski</surname><given-names>CE</given-names></name><name><surname>Kaikkonen</surname><given-names>MU</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell epigenomics and functional fine-mapping of atherosclerosis GWAS Loci</article-title><source>Circulation Research</source><volume>129</volume><fpage>240</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.121.318971</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Xue</surname><given-names>C</given-names></name><name><surname>Auerbach</surname><given-names>BJ</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Bashore</surname><given-names>AC</given-names></name><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>DY</given-names></name><name><surname>Trignano</surname><given-names>SB</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Ihuegbu</surname><given-names>CO</given-names></name><name><surname>Bush</surname><given-names>EC</given-names></name><name><surname>Worley</surname><given-names>J</given-names></name><name><surname>Vlahos</surname><given-names>L</given-names></name><name><surname>Laise</surname><given-names>P</given-names></name><name><surname>Solomon</surname><given-names>RA</given-names></name><name><surname>Connolly</surname><given-names>ES</given-names></name><name><surname>Califano</surname><given-names>A</given-names></name><name><surname>Sims</surname><given-names>PA</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Reilly</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human</article-title><source>Circulation</source><volume>142</volume><fpage>2060</fpage><lpage>2075</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.048378</pub-id><pub-id pub-id-type="pmid">32962412</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>MT</given-names></name><name><surname>Ferreira Melo</surname><given-names>FU</given-names></name><name><surname>Malta</surname><given-names>TM</given-names></name><name><surname>Rodrigues</surname><given-names>ES</given-names></name><name><surname>Plaça</surname><given-names>JR</given-names></name><name><surname>Silva</surname><given-names>WA</given-names></name><name><surname>Panepucci</surname><given-names>RA</given-names></name><name><surname>Covas</surname><given-names>DT</given-names></name><name><surname>de Oliveira Rodrigues</surname><given-names>C</given-names></name><name><surname>Kashima</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Endothelial cells from different anatomical origin have distinct responses during SNAIL/TGF-β2-mediated endothelial-mesenchymal transition</article-title><source>American Journal of Translational Research</source><volume>10</volume><fpage>4065</fpage><lpage>4081</lpage><pub-id pub-id-type="pmid">30662651</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MAR</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>de Bakker</surname><given-names>PIW</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title><source>American Journal of Human Genetics</source><volume>81</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1086/519795</pub-id><pub-id pub-id-type="pmid">17701901</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricciotti</surname><given-names>E</given-names></name><name><surname>FitzGerald</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Prostaglandins and inflammation</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>31</volume><fpage>986</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.110.207449</pub-id><pub-id pub-id-type="pmid">21508345</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Everett</surname><given-names>BM</given-names></name><name><surname>Thuren</surname><given-names>T</given-names></name><name><surname>MacFadyen</surname><given-names>JG</given-names></name><name><surname>Chang</surname><given-names>WH</given-names></name><name><surname>Ballantyne</surname><given-names>C</given-names></name><name><surname>Fonseca</surname><given-names>F</given-names></name><name><surname>Nicolau</surname><given-names>J</given-names></name><name><surname>Koenig</surname><given-names>W</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Kastelein</surname><given-names>JJP</given-names></name><name><surname>Cornel</surname><given-names>JH</given-names></name><name><surname>Pais</surname><given-names>P</given-names></name><name><surname>Pella</surname><given-names>D</given-names></name><name><surname>Genest</surname><given-names>J</given-names></name><name><surname>Cifkova</surname><given-names>R</given-names></name><name><surname>Lorenzatti</surname><given-names>A</given-names></name><name><surname>Forster</surname><given-names>T</given-names></name><name><surname>Kobalava</surname><given-names>Z</given-names></name><name><surname>Vida-Simiti</surname><given-names>L</given-names></name><name><surname>Flather</surname><given-names>M</given-names></name><name><surname>Shimokawa</surname><given-names>H</given-names></name><name><surname>Ogawa</surname><given-names>H</given-names></name><name><surname>Dellborg</surname><given-names>M</given-names></name><name><surname>Rossi</surname><given-names>PRF</given-names></name><name><surname>Troquay</surname><given-names>RPT</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Glynn</surname><given-names>RJ</given-names></name><collab>CANTOS Trial Group</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Antiinflammatory therapy with canakinumab for atherosclerotic disease</article-title><source>The New England Journal of Medicine</source><volume>377</volume><fpage>1119</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1707914</pub-id><pub-id pub-id-type="pmid">28845751</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodor</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>SH</given-names></name><name><surname>Scanlon</surname><given-names>JP</given-names></name><name><surname>Monteiro</surname><given-names>JP</given-names></name><name><surname>Caudrillier</surname><given-names>A</given-names></name><name><surname>Sweta</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>KR</given-names></name><name><surname>Shmakova</surname><given-names>A</given-names></name><name><surname>Dobie</surname><given-names>R</given-names></name><name><surname>Henderson</surname><given-names>BEP</given-names></name><name><surname>Stewart</surname><given-names>K</given-names></name><name><surname>Hadoke</surname><given-names>PWF</given-names></name><name><surname>Southwood</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>SD</given-names></name><name><surname>Upton</surname><given-names>PD</given-names></name><name><surname>Morrell</surname><given-names>NW</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Chan</surname><given-names>SY</given-names></name><name><surname>Handen</surname><given-names>A</given-names></name><name><surname>Lafyatis</surname><given-names>R</given-names></name><name><surname>de Rooij</surname><given-names>LPMH</given-names></name><name><surname>Henderson</surname><given-names>NC</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Spiroski</surname><given-names>AM</given-names></name><name><surname>Brittan</surname><given-names>M</given-names></name><name><surname>Baker</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension</article-title><source>Cardiovascular Research</source><volume>118</volume><fpage>2519</fpage><lpage>2534</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvab296</pub-id><pub-id pub-id-type="pmid">34528097</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohlenova</surname><given-names>K</given-names></name><name><surname>Goveia</surname><given-names>J</given-names></name><name><surname>García-Caballero</surname><given-names>M</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Kalucka</surname><given-names>J</given-names></name><name><surname>Treps</surname><given-names>L</given-names></name><name><surname>Falkenberg</surname><given-names>KD</given-names></name><name><surname>de Rooij</surname><given-names>LPMH</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Sokol</surname><given-names>L</given-names></name><name><surname>Teuwen</surname><given-names>L-A</given-names></name><name><surname>Geldhof</surname><given-names>V</given-names></name><name><surname>Taverna</surname><given-names>F</given-names></name><name><surname>Pircher</surname><given-names>A</given-names></name><name><surname>Conradi</surname><given-names>L-C</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Stegen</surname><given-names>S</given-names></name><name><surname>Panovska</surname><given-names>D</given-names></name><name><surname>De Smet</surname><given-names>F</given-names></name><name><surname>Staal</surname><given-names>FJT</given-names></name><name><surname>Mclaughlin</surname><given-names>RJ</given-names></name><name><surname>Vinckier</surname><given-names>S</given-names></name><name><surname>Van Bergen</surname><given-names>T</given-names></name><name><surname>Ectors</surname><given-names>N</given-names></name><name><surname>De Haes</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Bolund</surname><given-names>L</given-names></name><name><surname>Schoonjans</surname><given-names>L</given-names></name><name><surname>Karakach</surname><given-names>TK</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Carmeliet</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Thienpont</surname><given-names>B</given-names></name><name><surname>Dewerchin</surname><given-names>M</given-names></name><name><surname>Eelen</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-Cell RNA sequencing maps endothelial metabolic plasticity in pathological angiogenesis</article-title><source>Cell Metabolism</source><volume>31</volume><fpage>862</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2020.03.009</pub-id><pub-id pub-id-type="pmid">32268117</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Romanoski</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Adelus_2024_Elife</data-title><version designator="swh:1:rev:422d8dd1d5c72306e082574d327a84bdc1a5ea7e">swh:1:rev:422d8dd1d5c72306e082574d327a84bdc1a5ea7e</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:b2fa6bd8f76aa92f26cc08d73f44083af7d34c15;origin=https://github.com/cromanoski/Adelus_2024_Elife;visit=swh:1:snp:d8d052272f1daf28634d55fac0c4bb1d10c4fdd1;anchor=swh:1:rev:422d8dd1d5c72306e082574d327a84bdc1a5ea7e">https://archive.softwareheritage.org/swh:1:dir:b2fa6bd8f76aa92f26cc08d73f44083af7d34c15;origin=https://github.com/cromanoski/Adelus_2024_Elife;visit=swh:1:snp:d8d052272f1daf28634d55fac0c4bb1d10c4fdd1;anchor=swh:1:rev:422d8dd1d5c72306e082574d327a84bdc1a5ea7e</ext-link></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sánchez-Duffhues</surname><given-names>G</given-names></name><name><surname>García de Vinuesa</surname><given-names>A</given-names></name><name><surname>van de Pol</surname><given-names>V</given-names></name><name><surname>Geerts</surname><given-names>ME</given-names></name><name><surname>de Vries</surname><given-names>MR</given-names></name><name><surname>Janson</surname><given-names>SG</given-names></name><name><surname>van Dam</surname><given-names>H</given-names></name><name><surname>Lindeman</surname><given-names>JH</given-names></name><name><surname>Goumans</surname><given-names>M-J</given-names></name><name><surname>Ten Dijke</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2</article-title><source>The Journal of Pathology</source><volume>247</volume><fpage>333</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1002/path.5193</pub-id><pub-id pub-id-type="pmid">30430573</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schep</surname><given-names>AN</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Buenrostro</surname><given-names>JD</given-names></name><name><surname>Greenleaf</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data</article-title><source>Nature Methods</source><volume>14</volume><fpage>975</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4401</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>CA</given-names></name><name><surname>Rasband</surname><given-names>WS</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NIH Image to ImageJ: 25 years of image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>671</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmid">22930834</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sperone</surname><given-names>A</given-names></name><name><surname>Dryden</surname><given-names>NH</given-names></name><name><surname>Birdsey</surname><given-names>GM</given-names></name><name><surname>Madden</surname><given-names>L</given-names></name><name><surname>Johns</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>PC</given-names></name><name><surname>Mason</surname><given-names>JC</given-names></name><name><surname>Haskard</surname><given-names>DO</given-names></name><name><surname>Boyle</surname><given-names>JJ</given-names></name><name><surname>Paleolog</surname><given-names>EM</given-names></name><name><surname>Randi</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The transcription factor Erg inhibits vascular inflammation by repressing NF-kappaB activation and proinflammatory gene expression in endothelial cells</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>31</volume><fpage>142</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.110.216473</pub-id><pub-id pub-id-type="pmid">20966395</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenmark</surname><given-names>KR</given-names></name><name><surname>Frid</surname><given-names>M</given-names></name><name><surname>Perros</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Endothelial-to-mesenchymal transition: an evolving paradigm and a promising therapeutic target in PAH</article-title><source>Circulation</source><volume>133</volume><fpage>1734</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.116.022479</pub-id><pub-id pub-id-type="pmid">27045137</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolze</surname><given-names>LK</given-names></name><name><surname>Conklin</surname><given-names>AC</given-names></name><name><surname>Whalen</surname><given-names>MB</given-names></name><name><surname>López Rodríguez</surname><given-names>M</given-names></name><name><surname>Õunap</surname><given-names>K</given-names></name><name><surname>Selvarajan</surname><given-names>I</given-names></name><name><surname>Toropainen</surname><given-names>A</given-names></name><name><surname>Örd</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Eshghi</surname><given-names>A</given-names></name><name><surname>Solomon</surname><given-names>AE</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Kaikkonen</surname><given-names>MU</given-names></name><name><surname>Romanoski</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Systems genetics in human endothelial cells identifies non-coding variants modifying enhancers, expression, and complex disease traits</article-title><source>American Journal of Human Genetics</source><volume>106</volume><fpage>748</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2020.04.008</pub-id><pub-id pub-id-type="pmid">32442411</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Madad</surname><given-names>S</given-names></name><name><surname>Lareau</surname><given-names>CA</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell chromatin state analysis with Signac</article-title><source>Nature Methods</source><volume>18</volume><fpage>1333</fpage><lpage>1341</lpage><pub-id pub-id-type="doi">10.1038/s41592-021-01282-5</pub-id><pub-id pub-id-type="pmid">34725479</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suárez</surname><given-names>Y</given-names></name><name><surname>Fernández-Hernando</surname><given-names>C</given-names></name><name><surname>Pober</surname><given-names>JS</given-names></name><name><surname>Sessa</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells</article-title><source>Circulation Research</source><volume>100</volume><fpage>1164</fpage><lpage>1173</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000265065.26744.17</pub-id><pub-id pub-id-type="pmid">17379831</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tcheandjieu</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Hilliard</surname><given-names>AT</given-names></name><name><surname>Clarke</surname><given-names>SL</given-names></name><name><surname>Napolioni</surname><given-names>V</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>KM</given-names></name><name><surname>Fang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Tsao</surname><given-names>NL</given-names></name><name><surname>Raghavan</surname><given-names>S</given-names></name><name><surname>Koyama</surname><given-names>S</given-names></name><name><surname>Gorman</surname><given-names>BR</given-names></name><name><surname>Vujkovic</surname><given-names>M</given-names></name><name><surname>Klarin</surname><given-names>D</given-names></name><name><surname>Levin</surname><given-names>MG</given-names></name><name><surname>Sinnott-Armstrong</surname><given-names>N</given-names></name><name><surname>Wojcik</surname><given-names>GL</given-names></name><name><surname>Plomondon</surname><given-names>ME</given-names></name><name><surname>Maddox</surname><given-names>TM</given-names></name><name><surname>Waldo</surname><given-names>SW</given-names></name><name><surname>Bick</surname><given-names>AG</given-names></name><name><surname>Pyarajan</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>R</given-names></name><name><surname>Ho</surname><given-names>Y-L</given-names></name><name><surname>Buyske</surname><given-names>S</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Haessler</surname><given-names>J</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Do</surname><given-names>R</given-names></name><name><surname>Verbanck</surname><given-names>M</given-names></name><name><surname>Chaudhary</surname><given-names>K</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Avery</surname><given-names>CL</given-names></name><name><surname>Graff</surname><given-names>M</given-names></name><name><surname>Haiman</surname><given-names>CA</given-names></name><name><surname>Le Marchand</surname><given-names>L</given-names></name><name><surname>Wilkens</surname><given-names>LR</given-names></name><name><surname>Bis</surname><given-names>JC</given-names></name><name><surname>Leonard</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Giri</surname><given-names>A</given-names></name><name><surname>Dikilitas</surname><given-names>O</given-names></name><name><surname>Kullo</surname><given-names>IJ</given-names></name><name><surname>Stanaway</surname><given-names>IB</given-names></name><name><surname>Jarvik</surname><given-names>GP</given-names></name><name><surname>Gordon</surname><given-names>AS</given-names></name><name><surname>Hebbring</surname><given-names>S</given-names></name><name><surname>Namjou</surname><given-names>B</given-names></name><name><surname>Kaufman</surname><given-names>KM</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Ishigaki</surname><given-names>K</given-names></name><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Verma</surname><given-names>SS</given-names></name><name><surname>Ritchie</surname><given-names>MD</given-names></name><name><surname>Kember</surname><given-names>RL</given-names></name><name><surname>Baras</surname><given-names>A</given-names></name><name><surname>Lotta</surname><given-names>LA</given-names></name><collab>Regeneron Genetics Center</collab><collab>CARDIoGRAMplusC4D Consortium</collab><collab>Biobank Japan</collab><collab>Million Veteran Program</collab><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Hauser</surname><given-names>ER</given-names></name><name><surname>Miller</surname><given-names>DR</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Reaven</surname><given-names>PD</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Gaziano</surname><given-names>JM</given-names></name><name><surname>Natarajan</surname><given-names>P</given-names></name><name><surname>Huffman</surname><given-names>JE</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name><name><surname>Chang</surname><given-names>K-M</given-names></name><name><surname>Lynch</surname><given-names>JA</given-names></name><name><surname>Damrauer</surname><given-names>SM</given-names></name><name><surname>Wilson</surname><given-names>PWF</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>YV</given-names></name><name><surname>Tsao</surname><given-names>PS</given-names></name><name><surname>O’Donnell</surname><given-names>CJ</given-names></name><name><surname>Assimes</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Large-scale genome-wide association study of coronary artery disease in genetically diverse populations</article-title><source>Nature Medicine</source><volume>28</volume><fpage>1679</fpage><lpage>1692</lpage><pub-id pub-id-type="doi">10.1038/s41591-022-01891-3</pub-id><pub-id pub-id-type="pmid">35915156</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tombor</surname><given-names>L</given-names></name><name><surname>John</surname><given-names>D</given-names></name><name><surname>Glaser</surname><given-names>SF</given-names></name><name><surname>Luxan</surname><given-names>G</given-names></name><name><surname>Forte</surname><given-names>E</given-names></name><name><surname>Furtado</surname><given-names>M</given-names></name><name><surname>Rosenthal</surname><given-names>N</given-names></name><name><surname>Manavski</surname><given-names>Y</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Muhly-Reinholz</surname><given-names>M</given-names></name><name><surname>Looso</surname><given-names>M</given-names></name><name><surname>Acker</surname><given-names>T</given-names></name><name><surname>Harvey</surname><given-names>R</given-names></name><name><surname>Abplanalp</surname><given-names>A</given-names></name><name><surname>Dimmeler</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single cell sequencing reveals endothelial plasticity with transient mesenchymal activation after myocardial infarction</article-title><source>European Heart Journal</source><volume>41</volume><elocation-id>ehaa946</elocation-id><pub-id pub-id-type="doi">10.1093/ehjci/ehaa946.3736</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toropainen</surname><given-names>A</given-names></name><name><surname>Stolze</surname><given-names>LK</given-names></name><name><surname>Örd</surname><given-names>T</given-names></name><name><surname>Whalen</surname><given-names>MB</given-names></name><name><surname>Torrell</surname><given-names>PM</given-names></name><name><surname>Link</surname><given-names>VM</given-names></name><name><surname>Kaikkonen</surname><given-names>MU</given-names></name><name><surname>Romanoski</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Functional noncoding SNPs in human endothelial cells fine-map vascular trait associations</article-title><source>Genome Research</source><volume>32</volume><fpage>409</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1101/gr.276064.121</pub-id><pub-id pub-id-type="pmid">35193936</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turgeon</surname><given-names>PJ</given-names></name><name><surname>Chan</surname><given-names>GC</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Jamal</surname><given-names>AN</given-names></name><name><surname>Yan</surname><given-names>MS</given-names></name><name><surname>Ho</surname><given-names>JJD</given-names></name><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Ibeh</surname><given-names>N</given-names></name><name><surname>Ku</surname><given-names>KH</given-names></name><name><surname>Cybulsky</surname><given-names>MI</given-names></name><name><surname>Aird</surname><given-names>WC</given-names></name><name><surname>Marsden</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epigenetic heterogeneity and mitotic heritability prime endothelial cell gene induction</article-title><source>Journal of Immunology</source><volume>204</volume><fpage>1173</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1900744</pub-id><pub-id pub-id-type="pmid">31996458</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Meeteren</surname><given-names>LA</given-names></name><name><surname>ten Dijke</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Regulation of endothelial cell plasticity by TGF-β</article-title><source>Cell and Tissue Research</source><volume>347</volume><fpage>177</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1007/s00441-011-1222-6</pub-id><pub-id pub-id-type="pmid">21866313</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayaraj</surname><given-names>P</given-names></name><name><surname>Le Bras</surname><given-names>A</given-names></name><name><surname>Mitchell</surname><given-names>N</given-names></name><name><surname>Kondo</surname><given-names>M</given-names></name><name><surname>Juliao</surname><given-names>S</given-names></name><name><surname>Wasserman</surname><given-names>M</given-names></name><name><surname>Beeler</surname><given-names>D</given-names></name><name><surname>Spokes</surname><given-names>K</given-names></name><name><surname>Aird</surname><given-names>WC</given-names></name><name><surname>Baldwin</surname><given-names>HS</given-names></name><name><surname>Oettgen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Erg is a crucial regulator of endocardial-mesenchymal transformation during cardiac valve morphogenesis</article-title><source>Development</source><volume>139</volume><fpage>3973</fpage><lpage>3985</lpage><pub-id pub-id-type="doi">10.1242/dev.081596</pub-id><pub-id pub-id-type="pmid">22932696</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villanueva</surname><given-names>RAM</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>ggplot2: elegant graphics for data analysis</article-title><source>Measurement</source><volume>17</volume><fpage>160</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1080/15366367.2019.1565254</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Warnes</surname><given-names>GR</given-names></name><name><surname>Bolker</surname><given-names>B</given-names></name><name><surname>Bonebakker</surname><given-names>L</given-names></name><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Liaw</surname><given-names>WHA</given-names></name><name><surname>Lumley</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Gplots: various R programming tools for plotting data</data-title><source>R Package Version. 2014</source></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wirka</surname><given-names>RC</given-names></name><name><surname>Wagh</surname><given-names>D</given-names></name><name><surname>Paik</surname><given-names>DT</given-names></name><name><surname>Pjanic</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>CL</given-names></name><name><surname>Kundu</surname><given-names>R</given-names></name><name><surname>Nagao</surname><given-names>M</given-names></name><name><surname>Coller</surname><given-names>J</given-names></name><name><surname>Koyano</surname><given-names>TK</given-names></name><name><surname>Fong</surname><given-names>R</given-names></name><name><surname>Woo</surname><given-names>YJ</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Montgomery</surname><given-names>SB</given-names></name><name><surname>Wu</surname><given-names>JC</given-names></name><name><surname>Zhu</surname><given-names>K</given-names></name><name><surname>Chang</surname><given-names>R</given-names></name><name><surname>Alamprese</surname><given-names>M</given-names></name><name><surname>Tallquist</surname><given-names>MD</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Quertermous</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis</article-title><source>Nature Medicine</source><volume>25</volume><fpage>1280</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0512-5</pub-id><pub-id pub-id-type="pmid">31359001</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodfin</surname><given-names>A</given-names></name><name><surname>Voisin</surname><given-names>MB</given-names></name><name><surname>Nourshargh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>PECAM-1: a multi-functional molecule in inflammation and vascular biology</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>27</volume><fpage>2514</fpage><lpage>2523</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.107.151456</pub-id><pub-id pub-id-type="pmid">17872453</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Sellke</surname><given-names>FW</given-names></name><name><surname>Dong</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cell-type transcriptome atlas of human aortic valves reveal cell heterogeneity and endothelial to mesenchymal transition involved in calcific aortic valve disease</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>40</volume><fpage>2910</fpage><lpage>2921</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.120.314789</pub-id><pub-id pub-id-type="pmid">33086873</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>F</given-names></name><name><surname>Powell</surname><given-names>DR</given-names></name><name><surname>Curtis</surname><given-names>DJ</given-names></name><name><surname>Wong</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>From reads to insight: a hitchhiker’s guide to ATAC-seq data analysis</article-title><source>Genome Biology</source><volume>21</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1186/s13059-020-1929-3</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Ng</surname><given-names>FL</given-names></name><name><surname>Chan</surname><given-names>K</given-names></name><name><surname>Pu</surname><given-names>X</given-names></name><name><surname>Poston</surname><given-names>RN</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>An</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>S</given-names></name><name><surname>Situ</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>Q</given-names></name><name><surname>Tucker</surname><given-names>AT</given-names></name><name><surname>Caulfield</surname><given-names>MJ</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Coronary-heart-disease-associated genetic variant at the COL4A1/COL4A2 Locus Affects COL4A1/COL4A2 expression, vascular cell survival, atherosclerotic plaque stability and risk of myocardial infarction</article-title><source>PLOS Genetics</source><volume>12</volume><elocation-id>e1006127</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006127</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Chan</surname><given-names>GC</given-names></name><name><surname>Beeler</surname><given-names>D</given-names></name><name><surname>Janes</surname><given-names>L</given-names></name><name><surname>Spokes</surname><given-names>KC</given-names></name><name><surname>Dharaneeswaran</surname><given-names>H</given-names></name><name><surname>Mojiri</surname><given-names>A</given-names></name><name><surname>Adams</surname><given-names>WJ</given-names></name><name><surname>Sciuto</surname><given-names>T</given-names></name><name><surname>Garcia-Cardeña</surname><given-names>G</given-names></name><name><surname>Molema</surname><given-names>G</given-names></name><name><surname>Kang</surname><given-names>PM</given-names></name><name><surname>Jahroudi</surname><given-names>N</given-names></name><name><surname>Marsden</surname><given-names>PA</given-names></name><name><surname>Dvorak</surname><given-names>A</given-names></name><name><surname>Regan</surname><given-names>ER</given-names></name><name><surname>Aird</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A role of stochastic phenotype switching in generating mosaic endothelial cell heterogeneity</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>10160</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10160</pub-id><pub-id pub-id-type="pmid">26744078</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Tong</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Single cell meta-analysis of EndMT and EMT state in COVID-19</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>976512</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.976512</pub-id><pub-id pub-id-type="pmid">36248845</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Eichten</surname><given-names>A</given-names></name><name><surname>Parveen</surname><given-names>A</given-names></name><name><surname>Adler</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Adler</surname><given-names>A</given-names></name><name><surname>Nevins</surname><given-names>T</given-names></name><name><surname>Ni</surname><given-names>M</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Thurston</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell transcriptome analyses reveal endothelial cell heterogeneity in tumors and changes following antiangiogenic treatment</article-title><source>Cancer Research</source><volume>78</volume><fpage>2370</fpage><lpage>2382</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-2728</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Chang</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>T</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Garcia-Barrio</surname><given-names>MT</given-names></name><name><surname>Chen</surname><given-names>YE</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>Single-cell RNA sequencing reveals the cellular heterogeneity of aneurysmal infrarenal abdominal aorta</article-title><source>Cardiovascular Research</source><volume>117</volume><fpage>1402</fpage><lpage>1416</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvaa214</pub-id><pub-id pub-id-type="pmid">32678909</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>T</given-names></name><name><surname>Garcia-Barrio</surname><given-names>MT</given-names></name><name><surname>Chen</surname><given-names>YE</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>Single-cell transcriptomics reveals endothelial plasticity during diabetic atherogenesis</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>689469</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.689469</pub-id><pub-id pub-id-type="pmid">34095155</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>GXY</given-names></name><name><surname>Terry</surname><given-names>JM</given-names></name><name><surname>Belgrader</surname><given-names>P</given-names></name><name><surname>Ryvkin</surname><given-names>P</given-names></name><name><surname>Bent</surname><given-names>ZW</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Ziraldo</surname><given-names>SB</given-names></name><name><surname>Wheeler</surname><given-names>TD</given-names></name><name><surname>McDermott</surname><given-names>GP</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Gregory</surname><given-names>MT</given-names></name><name><surname>Shuga</surname><given-names>J</given-names></name><name><surname>Montesclaros</surname><given-names>L</given-names></name><name><surname>Underwood</surname><given-names>JG</given-names></name><name><surname>Masquelier</surname><given-names>DA</given-names></name><name><surname>Nishimura</surname><given-names>SY</given-names></name><name><surname>Schnall-Levin</surname><given-names>M</given-names></name><name><surname>Wyatt</surname><given-names>PW</given-names></name><name><surname>Hindson</surname><given-names>CM</given-names></name><name><surname>Bharadwaj</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Ness</surname><given-names>KD</given-names></name><name><surname>Beppu</surname><given-names>LW</given-names></name><name><surname>Deeg</surname><given-names>HJ</given-names></name><name><surname>McFarland</surname><given-names>C</given-names></name><name><surname>Loeb</surname><given-names>KR</given-names></name><name><surname>Valente</surname><given-names>WJ</given-names></name><name><surname>Ericson</surname><given-names>NG</given-names></name><name><surname>Stevens</surname><given-names>EA</given-names></name><name><surname>Radich</surname><given-names>JP</given-names></name><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Hindson</surname><given-names>BJ</given-names></name><name><surname>Bielas</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Massively parallel digital transcriptional profiling of single cells</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14049</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14049</pub-id><pub-id pub-id-type="pmid">28091601</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Pache</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Khodabakhshi</surname><given-names>AH</given-names></name><name><surname>Tanaseichuk</surname><given-names>O</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Chanda</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title><source>Nature Communications</source><volume>10</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.91729.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Seldin</surname><given-names>Marcus M</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of California, Irvine</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Fundamental</kwd></kwd-group></front-stub><body><p>This is a <bold>fundamental</bold> resource of snRNA-seq and chromatin accessibility data from human aortic endothelial cells (ECs), treated with relevant perturbations such as IL1b, TGFB2, or siERG. The authors show that ECs can be categorized by distinct subpopulations of differing plasticity. The support for the existence of these subpopulations is <bold>compelling</bold>, supported also by three publicly available scRNA-seq datasets, and differential enrichment of coronary artery disease associated SNPs in open chromatin in these subpopulations.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.91729.3.sa1</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>This study by Adelus et al. profiled the transcriptome and chromatin accessibility in cultured human aortic endothelial cells (ECs) at single-cell resolution. They also stimulated these cells with EC-activating agents, such as IL1b, TGFB2, or siEGR, to knock down this master transcription factor in ECs. The results show a subpopulation, EC3, with the highest plasticity and sensitivity to perturbations. The authors also reviewed and meta-analyzed three independent publicly available scRNA-seq datasets, identifying two distinct EC subpopulations. Additionally, they aligned CAD-related SNPs with open chromatin regions in EC subpopulations. This study provides fundamental evidence to enrich our understanding of vascular ECs and highlights potential subpopulations that may contribute to health and diseases. The work exhibits the potential impact in the field.</p><p>Comments on revised version:</p><p>I appreciate their revision, which addressed all my concerns. I understand the current technique's limitation in distinguishing bona fide cell lineages from human tissue explants, but it merits further investigation. This is because EC4 may also be involved in critical pathological processes. Again, this work established a solid foundation for exploring endothelial cell plasticity.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.91729.3.sa2</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Adelus</surname><given-names>Maria L</given-names></name><role specific-use="author">Author</role><aff><institution>University of Arizona</institution><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Ding</surname><given-names>Jiacheng</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Arizona</institution><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Tran</surname><given-names>Binh T</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Arizona</institution><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Conklin</surname><given-names>Austin C</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Arizona</institution><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Golebiewski</surname><given-names>Anna K</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Arizona</institution><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Stolze</surname><given-names>Lindsey K</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Arizona</institution><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Whalen</surname><given-names>Michael B</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Arizona</institution><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Cusanovich</surname><given-names>Darren A</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Arizona</institution><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Romanoski</surname><given-names>Casey E</given-names></name><role specific-use="author">Author</role><aff><institution>University of Arizona</institution><addr-line><named-content content-type="city">Tucson</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>The manuscript by Adelus and colleagues investigates the snRNA sequencing of endothelial cells isolated from deceased heart donor aortic trimmings. From n=6 donors, the authors have identified 5 distinct endothelial cell (EC) populations. The expression levels of a set of genes are different among the different donors and different EC clusters. Furthermore, treatment with IL1B, TGFB, or ERGsi decreased the proportion of some of these clusters and increased others, with some migratory and ECM-producing capacity. Another interesting observation in this study is that IL-1B alone induces a shift in the clusters and that is different from the TGFB-induced cells. However, ex vivo analyses showed most of the TGFB-induced population matched the in vitro observations. Another interesting finding of the work is that the authors detected SNPs linked to chromatin accessibility to the set of genes identified within these EC populations.</p><p>Strengths:</p><p>Overall, the work is intriguing and has some novel aspects to it, especially the link between ECderived EndMT in culture and comparing that with ex vivo atherosclerotic samples.</p></disp-quote><p>In summary, we thank we thank Reviewer #1 for raising questions that prompted new speculations and clarifications of our data. We hope this Reviewer will now find our revised manuscript suitable for publication.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>The experiments are lacking in controls, the purity of the isolation, and the use of multiple donors (deceased hearts) to draw conclusions. The lack of validation of the work is a concern.</p></disp-quote><p>We thank Reviewer #1 for raising these concerns. Controls were not available in the public in vivo data, likely due to the systemic nature of coronary artery disease (CAD) and the logistical difficulty in obtaining arterial samples from healthy participants. With respect to our in vitro data, controls were included in the design. We agree that it is critical to validate functions of endothelial cell (EC) populations with functional studies, and this is the subject of ongoing and future work. Regarding asymmetry of donors, we aimed to have at least three replicate donors per condition. In the study design, we had to load genetically different donors per 10x lane, which is why we utilized different donors for each condition. We address the purity of isolation in our response to Reviewer #2 below.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>This study by Adelus et al. profiled the transcriptome and chromatin accessibility in cultured human aortic endothelial cells (ECs) at single-cell resolution. They also stimulated these cells with EC-activating agents, such as IL1b, TGFB2, or siEGR, to knock down this master transcription factor in ECs. The results show a subpopulation, EC3, with the highest plasticity and sensitivity to perturbations. The authors also reviewed and meta-analyzed three independent publicly available scRNA-seq datasets, identifying two distinct EC subpopulations. Additionally, they aligned CAD-related SNPs with open chromatin regions in EC subpopulations. This study provides fundamental evidence to enrich our understanding of vascular ECs and highlights potential subpopulations that may contribute to health and diseases. The work exhibits the potential impact in the field. While the manuscript is comprehensive, there are some concerns that should be addressed.</p><p>(1) My major concern is whether EC4 is derived from ECs. It seems that EC4 showed a lesser reaction to those perturbations and had lower expression levels of EC marker genes. Did the authors evaluate the purity of their isolated HAECs? Please discuss the potential cell lineage mapping of EC4.</p></disp-quote><p>We thank Reviewer #2 for raising the question on the purity of isolation. We have now included this in the Discussion:</p><p>“A major question raised by this work is the origin of cells in the mesenchymal cluster EC4. We originally hypothesized this cluster was the result of EndMT, which led to our investigations as to whether we could leverage EndMT-promoting exposures (IL1B, TGFB2, siERG) in vitro observe an expansion of treated cells in the EC4 population. To our surprise, the EC4 population did not expand. If anything, these exposures reduced the proportion of cells in ECs (Figure 4). Nonetheless, it remains a possibility that EC4 represents cells that had undergone EndMT in vivo prior to culture and that the exposures we presented in vitro were not sufficient to elicit a complete EndMT transition. Another viable hypothesis is that cells in EC4 are of SMC origin and have persisted in culture alongside their EC counterparts. Cells used in this study were isolated by luminal collagenase digestion of explanted aortic segments and were tested at early passage for EC phenotypic markers including VWF expression, cobblestone morphology, and uptake of acetylated LDL. Notably, these rigorous metrics to ensure pure EC isolation occurred prior to our group’s studies. In addition, if some of the isolated cells had undergone EndMT in vivo prior to isolation, it would be nearly impossible to distinguish their cell of origin after isolation since their collective molecular phenotypes would appear as an SMC. Without lineage tracing, which is currently not possible in human tissue explants, it would not be possible to distinguish cell origin. Nonetheless, this remains an important issue that is the subject of ongoing investigations. What we can confidently discern from these data is that these distinct cell subpopulations respond differently to the disease-relevant exposures of IL1B, TGFB2, and ERG depletion.”</p><disp-quote content-type="editor-comment"><p>(2) Although all the donors are de-identified, is there any information about the severity of their vascular impairment, particularly in the case of patient 5, who exhibits the unique EC5?</p></disp-quote><p>All donors are de-identified, and we only have access to their genotypes. We have now clarified this in Methods, “Tissue Procurement and Cell Culture”:” Primary HAECs were isolated from eight de-identified deceased heart donor aortic trimmings (belonging to three females and five males of Admixed Americans, European, and East Asian ancestries) at the University ofCalifornia Los Angeles Hospital as described previously (42) (Table S7 in the Data Supplement).The only clinically relevant information collected for each donor was their genotype (Methods, “Genotyping and Multiplexing Cell Barcodes for Donor Identification”).”</p><disp-quote content-type="editor-comment"><p>(3) The meta-analysis of the published datasets is comprehensive. The identified EC heterogeneity corresponds to their in vitro data. I am wondering, in terms of transcriptome, is there any similarity between endo1 and EC1/EC2, and also endo2 and EC3/EC4?</p></disp-quote><p>This was addressed in Results, “Ex Vivo-derived Module Score Analysis Reveals Differences among In Vitro EC Subtypes and EndMT Stimuli”: “Cells scoring high for Endo1 are concentrated in the in vitro EC1 cluster, while cells scoring high in Endo2 are concentrated to the in vitro EC3 locale (Figure S7B-E in the Data Supplement).”</p><disp-quote content-type="editor-comment"><p>(4) The in vitro data indicates that EC3 shows the highest plasticity and sensitivity to perturbations, which may act as the major subtype of ECs responding to risk factors. It's very interesting that CAD-related SNPs do not seem to be enriched in EC3. Please discuss this discrepancy.</p></disp-quote><p>We thank Reviewer #2 for bringing up this interesting point, which we have now included in our Discussion: “While EC3 was found to be more sensitive to perturbations in our in vitro experiments, we did not expect to see CAD-related SNPs enriched in EC3 because plasticity does not necessarily imply a pathological process. Moreover, while EC3 and EC4 both have mesenchymal phenotypes, EC3 may represent a reversible state that is lacking in EC4. This hypothesis would explain the enrichment of EC4, but not EC3, in CAD-related SNPs.”</p><disp-quote content-type="editor-comment"><p>(5) The last sentence in the legend of Figure 1 seems incomplete: 'Module scores are generated for each cell barcode with Seurat function AddModuleScore().'</p></disp-quote><p>We have made changes to this sentence so that it now reads: “Module scores are generated for each cell barcode with the Seurat function AddModuleScore().”</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>The manuscript by Adelus and colleagues investigates the snRNA sequencing of endothelial cells isolated from deceased heart donor aortic trimmings. From n=6 donors, the authors have identified 5 distinct endothelial cell (EC) populations. The expression levels of a set of genes are different among the different donors and different EC clusters. Furthermore, treatment with IL1B, TGFB, or ERGsi decreased the proportion of some of these clusters and increased others, with some migratory and ECM-producing capacity. Another interesting observation in this study is that IL-1B alone induces a shift in the clusters and that is different from the TGFB-induced cells. However ex vivo analyses showed most of the TGFB-induced population are the ones that matched the in vitro observations. Another interesting finding of the work is that the authors detected SNPs linked to chromatin accessibility to the set of genes identified within these EC populations. Overall, the work is intriguing and has some novel aspects to it, especially the link between EC-derived EndMT in culture and comparing that with ex vivo atherosclerotic samples. However, the experiments are lacking in controls, the purity of the isolation, and the use of multiple donors (deceased hearts) to draw conclusions. The lack of validations for the work is a huge concern. Additional major and minor concerns are:</p><p>Major concerns:</p><p>(1) Abstract: line 15: ECs are a major cell type in atherosclerosis progression - That is a bold statement: What about macrophages and VSMCs?</p></disp-quote><p>We have made changes to this sentence so that it now reads: “Endothelial cells (ECs), macrophages, and vascular smooth muscle cells (VSMCs) are major cell types in atherosclerosis progression, and heterogeneity in EC sub-phenotypes are becoming increasingly appreciated.”</p><disp-quote content-type="editor-comment"><p>(2) Methods: The cells were isolated from the deceased heart by a device? What kind of device? Is it a standard method, showing a figure or data suggesting the purity of the isolates. Also, the authors mentioned that they assessed EC function, but no single figure suggests that. Why were the cells treated with fibronectin?</p></disp-quote><p>We thank Reviewer #1 for bringing this to our attention. We did not isolate and identify the cells ourselves. This was done in a prior study as described in reference 41. The only function of the device was to hold the aortic explanted tissue in place so the luminal surface of the ECs could be digested with collagenase. We have made edits to clarify these points in Methods, “Tissue Procurement and Cell Culture”: “HAECs were isolated from the luminal surface of the aortic trimmings using collagenase, and identified by Navab et al. using their typical cobblestone morphology, presence of Factor VIII-related antigen, and uptake of acetylated LDL labeled with 1,1’-dioctadecyl-1-3,3,3’,3’-tetramethyl-indo-carbocyan-ine perchlorate (Di-acyetl-LD) (42).”</p><disp-quote content-type="editor-comment"><p>(3) Why did the authors elect to treat each donor cell with different treatment types and different concentrations, also why 1ng/ml of IL-1B?</p></disp-quote><p>We have addressed the study design asymmetry above. We chose the treatments because we questioned whether HAECs responded heterogeneously to these stimuli. We were interested in using these stimuli, because they have previously been used in vitro to induce EndMT and/or inflammation, two major pathophysiological processes in CAD. This is outlined in the Introduction: “We also quantified single cell responses to three perturbations known to be important in EC biology and atherosclerosis. The first was activation of transforming growth factor beta (TGFB) signaling, which is a hallmark of phenotypic transition and a regulator of EC heterogeneity (20, 30). The second was stimulation with the pro-inflammatory cytokine interleukin-1 beta (IL1B), which has been shown to model inflammation and EndMT in vitro (31-35), and whose inhibition reduced adverse cardiovascular events in a large clinical trial (36). The third perturbation utilized in our study was knock-down of the ETS related gene (ERG), which encodes a transcription factor of critical importance for EC fate specification and homeostasis (37-41).”</p><disp-quote content-type="editor-comment"><p>(4) The justification for comparing the EC population in ERGsi is unclear? This was detected as the highest in EC2 but EC2 is not the main cell type across the donors.</p></disp-quote><p>We include a justification for comparing the EC populations with siERG in the Introduction:</p><p>“There are notable benefits and limitations for studying heterogeneity using in vitro and in vivo approaches in atherosclerosis research. In vitro approaches provide unique opportunities for interrogating consequences of genetic and chemical perturbations in highly controlled environments and are adept at identifying mechanistic relationships on accelerated timelines.”</p><p>…and…</p><p>“We… quantified single cell responses to three perturbations known to be important in EC biology and atherosclerosis…The third perturbation utilized in our study was knock-down of the ETS related gene (ERG), which encodes a transcription factor of critical importance for EC fate specification and homeostasis (37-41).”</p><p>Notably, we found the highest proportion of cells in EC3 with siERG, not EC2:</p><p>The one cluster exhibiting increased proportions of cells upon EndMT perturbations was EC3, with 3 of 4 EC IL1B-exposed donors having increased proportions in EC3 (p = 0.08 by 2-sided paired t-test; Figure 3A), 4 of 5 TGFB2-exposed donors having increased proportions (p = 0.04 by 2-sided paired t-test; Figure 3A), and 3 of 3 donors having increased EC3 proportions upon ERG knock-down (Figure 3B).</p><disp-quote content-type="editor-comment"><p>(5) The different proportions of clusters per donor and their responses are different. These donors are from deceased hearts, could the postmortem induce changes in the ECs? The presence of SMC pathways in their analysis may indicate SMC contamination within the isolation rather than EndMT?</p></disp-quote><p>We have now included the possibility of postmortem effects in the Discussion:</p><p>“We cannot exclude the possibility that EC3 is an EndMT cluster, although we would have expected more significant deviation from clusters EC1 and EC2. It is also possible that the postmortem could induce changes in the ECs, or that the duration and doses of perturbations chosen were not sufficient to elicit complete EndMT.”</p><p>As aforementioned, we addressed the purity of isolation within the Discussion.</p><disp-quote content-type="editor-comment"><p>(6) Figure 4A is confusing, what do the dots indicate and the intersection size mean? What is the difference between Figure 4 C and 4 E?</p></disp-quote><p>We have added a description of rows and columns to the legend for Figure 4A:</p><p>“(A), Upset plots of up- and down-regulated DEGs across EC subtypes with siERG (grey), IL1B (pink), and TGFB2 (blue). Upset plots visualize intersections between sets in a matrix, where the columns of the matrix correspond to the sets, and the rows correspond to the intersections. Intersection size represents the number of genes at each intersection.”</p><p>Figure 4E depicts up- and down-regulated DEGs that are mutually exclusive and shared between IL1B and siERG in EC3, whereas Figure 4C depecits up- and down-regulated DEGs with IL1B alone compared to siSCR in EC2, EC3, and EC4. This is described within the legend for Figure 4C and Figure 4E:</p><p>“(C), PEA for EC2-4 up- and down-regulated DEGs with IL1B compared to control media… (E), PEA comparing up- and down-regulated DEGs that are mutually exclusive and shared between IL1B and siERG in EC3.”</p><disp-quote content-type="editor-comment"><p>(7) VSMCS 5 in Figure 5 is interesting, but it could be contaminated with SMCs in your EC population and they are SMCs indeed with some mesenchymal transdifferentiation?</p></disp-quote><p>As abovementioned, we addressed the purity of isolation within the Discussion.</p><disp-quote content-type="editor-comment"><p>Minor concerns:</p><p>(1) All growth supplements, kits, and reagents should be provided with their sources and catalogue numbers.</p></disp-quote><p>Sources and catalogue numbers have now been added to the following Methods sections:</p><p>“Tissue Procurement and Cell Culture”: “Cells were grown in culture in M-199 (ThermoFisher Scientific, Waltham, MA, MT-10-060-CV) supplemented with 1.2% sodium pyruvate(ThermoFisher Scientific, cat. no. 11360070), 1% 100X Pen Strep Glutamine (ThermoFisherScientific, cat. no. 10378016), 20% fetal bovine serum (FBS, GE Healthcare, Hyclone, Pittsburgh, PA), 1.6% Endothelial Cell Growth Serum (Corning, Corning, NY, cat. no. 356006), 1.6% heparin, and 10µL/50 mL Amphotericin B (ThermoFisher Scientific, cat. no. 15290018). HAECs at low passage (passage 3-6) were treated prior to harvest every 2 days for 7 days with either 10 ng/mL TGFB2 (ThermoFisher Scientific, cat. no. 302B2002CF), IL1B (ThermoFisher Scientific, cat. no. 201LB005CF), or no additional protein, or two doses of small interfering RNA for ERG locus (siERG; Table S18 in the Data Supplement), or randomized siRNA (siSCR; Table S18 in the Data Supplement).”</p><p>…and…</p><p>“siRNA Knock-down, qPCR, and Western Blotting”: “Knockdown of ERG was performed as previously described (40) using 1 nM siRNA oligonucleotides in OptiMEM (ThermoFisher Scientific, cat. no. 11058021) with Lipofectamine 2000 (ThermoFisher Scientific, cat. no. 11668030).”</p><disp-quote content-type="editor-comment"><p>(2) The quantification of western blot how?</p></disp-quote><p>Methods, “siRNA Knock-down, qPCR, and Western Blotting” now reads: “Western blots were quantified using ImageJ (76).”</p><disp-quote content-type="editor-comment"><p>(3) All the supplemental figures are listed incorrectly in the manuscript. For example, the authors refer to Figure S11B which should be S10. Please review the manuscript throughout to refer to the correct figures.</p></disp-quote><p>We thank Reviewer #1 for bringing this to our attention. Figure S4 was missing, leading to incorrectly listed supplemental figures for Figures S4-S12. Figure S4 has now been included, and Figures S4-S12 are now listed correctly within the manuscript text.</p><disp-quote content-type="editor-comment"><p>(4) Please refer to IL-1B as IL-1beta, same with TGFB.</p></disp-quote><p>We have left the terms as is, since it is also routine to refer to IL-1beta as IL1B, and TGFbeta as TGFB.</p><disp-quote content-type="editor-comment"><p>(5) here are typos throughout the manuscript, such as 4C, VW Fexpression, VWFand VCAM-1.</p></disp-quote><p>We could not locate typos “VW Fexpression” or “VWFand VCAM-1”. We do not consider “4C” a typo, as it refers to the temperature at which the centrifuge was set to in Methods, “Nuclear Dissociation and Library Preparation”: “Samples were centrifuged at 500 rcf for 5 minutes at4C…”</p><disp-quote content-type="editor-comment"><p>(6) Please define the abbreviations: line 69 and also cite the source of the use of aSMA/PECAM1 as EndMT?</p></disp-quote><p>We have now included abbreviation definitions and the cited source for ECs that co-express aSMA/PECAM-1 in atherosclerotic lesions within the Introduction: “These studies have described an unexpectedly large number of cells co-expressing pairs of endothelial and mesenchymal proteins, including fibroblast activating protein/von Willebrand factor (FAP/VWF), fibroblastspecific protein-1/VWF (FSP-1/VWF), FAP/platelet-endothelial cell adhesion molecule-1 (CD31 or PECAM-1), FSP-1/CD31 (20), phosphorylation of TGFB signaling intermediary SMAD2/FGF receptor 1 (p-SMAD2/FGFR1) (22), and α-smooth muscle actin (αSMA)/PECAM-1 (23).”</p><disp-quote content-type="editor-comment"><p>(7) The changes in % cells in cluster per donor per condition in Figure 3 are interesting, have the authors observed a change of one cluster at the expense of another i.e. do they transdifferentiate into another with different treatments?</p></disp-quote><p>Figure 3 shows that as percent of cells in EC3 go up with TGFB or IL1B, they go down in EC4 with these treatments. This has been added to the Discussion: “Moreover, as the percent of cells in EC3 go up with TGFB or IL1B, they go down in EC4, suggesting trans-differentiation from EC4 into EC3 with these perturbations.”</p><disp-quote content-type="editor-comment"><p>(8) Functional analysis of these clusters with and without treatment is required to confirm the EndMT.</p></disp-quote><p>We do not claim that the cells underwent EndMT. Rather, we use pro-EndMT perturbations previously described in the literature to test whether ECs respond heterogeneously to stimuli which are relevant to CAD. We found that EC subtype was a greater determinant of cell state than treatment.</p><disp-quote content-type="editor-comment"><p>(9) No blank line at 266. The break is in the middle of the sentence, also cytoplasmic cytoplasmic ribosomal proteins (typo?).</p></disp-quote><p>We have revised these sentences to read: “Shared IL1B- and siERG-upregulated genes were enriched in COVID-19 adverse outcome pathway (WP4891; p-value 1.9x10-9) (52). Shared IL1B- and siERG-attenuated genes are enriched in several processes involving ribosomal proteins, including ribosome, cytoplasmic (CORUM:306; p-value 3.3x10-7), cytoplasmic ribosomal proteins (WP477; p-value 5.3x10-7), and peptide chain elongation (R-HSA-156902; pvalue 5.9x10-7) (Figure 4E).”</p><disp-quote content-type="editor-comment"><p>(10) The sentence in line 321 &quot;These observations support ....of human, seems incomplete.</p></disp-quote><p>We revised these sentences to read: “Expected pathway enrichments are observed for annotated cell types, including NABA CORE MATRISOME (M5884; p-value 4.8x10-41) for fibroblasts, blood vessel development (GO:0001568; p-value 5.6x10-33) for ECs, and actin cytoskeleton organization (GO:0030036; p-value 1.3x10-15) for VSMCs (Figure S5D-G in the Data Supplement). These observations support the diverse composition of human atherosclerotic lesions.”</p><disp-quote content-type="editor-comment"><p>(11) What do the authors mean by (at least partially) line 444?</p></disp-quote><p>We revised this sentence to read: “In fact, the limited correlation with ex vivo data supports this interpretation.”</p><disp-quote content-type="editor-comment"><p>(12) Some unrelated data in the paper, like supplemental figure 10B and supplemental figure 11?</p></disp-quote><p>These data are relevant to methods, and have been kept.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>We need this work to expand our knowledge of endothelial biology. Please address my concerns to further strengthen this work.</p></disp-quote></body></sub-article></article>